Trading for the Masses

17:54 WRE Washington REIT beats by $0.01; raises FY07 FFO’s above consensus (33.70 -0.14)

Reports Q3 (Sept) funds from operations of $0.59 per share, $0.01 better than the Reuters Estimates consensus of $0.58; revenues rose 20.3% year/year to $66.0 mln vs the $64.2 mln consensus. Co raises Fy07 FFO’s to $2.23-2.26 vs $2.29 Reuters consensus, up from $2.23-2.26.
17:47 AEIS Advanced Energy: Conference call summary (15.83 -0.47) -Update-

Co continues to experience softness in demand from semiconductor capital and equipment industry and they continue to make progress in the strategic diversification of their business. The co mentions their solar invertor product line. For Q4 the co expects the weakness in the semi markets to continue. Short term, they do not anticipate the share gains will offset the effects of the industry fluctuations. Co expected seasonal softness in data storage and normal fluctuation in the glass markets. Co says they were encouraged to see L.C.D panel manufacturers return to profitability sooner than anticipated. The co believes the growing penetration of low E glass in commercial and residential construction, the increased complexity on the glass will drive sales to the first half of 2008 and throughout 2009. Co says with respect to extraordinary inventory levels that would create a protracted distance between them and the performance of the regular market, it’s the supply chain that is run pretty tight right now. So the co says they don’t think they see anything in the inventory range that would prevent them from performing with the overall market.
17:45 MYL Mylan Labs: Study found perforomist safe and effective - DJ

…
17:45 GGG Glencairn Gold: Bellavista Update. Glencairn notes significant damage to the structure of its ADR recovery plant -Update-

…
17:43 SFG prelim $1.29 vs $1.07 Reuters consensus

17:39 FORM FormFactor Conf Call Summary (43.24 -0.2 -Update-

Co guided Q4 EPS to $0.40-0.44 vs 0.43 consensus; guided revs to $123-128 mln vs $131.62 mln consensus. Co notes that guidance largely a function of difficult Harmony ramp. Expects to focus on Harmony ramp in Q4 & thinks may extend into early part of Q1… With respect to accounting review (which prevented co from releasing detailed financial data), co suggests will cover 2007 and possibly beyond. Indicates that it focuses on inventory valuation. Asked if co sees next yr more front-end or back-end loaded, co responded that it would prefer to wait until next call to discuss.. Stock trading at $37.50 in after hours, making new lows as the conf call progressed.
17:39 ACMR AC Moore beats by $0.02, misses on revs; updates inventory accounting review (16.23 -0.10)

Reports Q3 (Sep) loss of $0.02 per share, $0.02 better than the Reuters Estimates consensus of ($0.04); revenues fell 4.9% year/year to $122.6 mln vs the $130.3 mln consensus. Historically, the Company has valued store inventory on the retail inventory method at each year end. Inventory balances calculated under R.I.M. approximate inventory balances that would have been obtained if every item of inventory had been valued at the Company’s purchase price through the use of a specific costing method. The Company has used R.I.M. to determine year-end inventory balances because the Company’s systems did not allow for scanning of each stock-keeping unit during year-end counting of physical inventories at the Company’s stores. For the first three quarters of each year, the Company used a S.C.M. for purposes of determining cost of sales. Through its point of sale systems, the Company is able to assign a SKU-specific cost to every item sold. Using this data along with estimated inventory shrinkage factors, the Company estimates interim cost of sales and inventory. Because a S.C.M. was used during these periods, management believes it is unlikely that results of operations for the first three quarters of 2007 and 2006 will be materially affected by this matter. Inventory held in the Company’s distribution center has historically been and is currently valued for all periods during the year using a S.C.M… Based on preliminary data, management estimates that total inventory for all periods between December 31, 2004 and June 30, 2007 may be overstated in the range of $15.0 million to $25.0 million.
17:38 EGP EastGroup beats by $0.04, beats on revs; guides Q4 EPS above consensus (44.80 +0.09)

Reports Q3 (Sep) funds from operations of $0.80 per share, $0.04 better than the Reuters Estimates consensus of $0.76; revenues rose 16.3% year/year to $39.2 mln vs the $38.1 mln consensus. Co issues upside guidance for Q4, sees FFO of $0.84-0.86 vs. $0.79 consensus.
17:37 GRP Grant Prideco misses by $0.01, misses on revs; guides Q4 EPS below consensus (52.20 -0.41)

Reports Q3 (Sep) earnings of $0.96 per share, $0.01 worse than the Reuters Estimates consensus of $0.97; revenues rose 14.6% year/year to $539.9 mln vs the $547.6 mln consensus. Co issues downside guidance for Q4, sees EPS of $1.09-1.11 vs. $1.12 consensus; expects revenues to improve at all three of our divisions.
17:37 AKAM Akamai Tech Conf Call Summary (32.97 ) -Update-

Added 61 new customers in target market bringing total customers to 2,616. ARPU grew 3% sequentially and 18% y/y. Cash gross margins were 82%, down 50 basis points sequentially. Noting that results put them on track to deliver on their full year gross margin guidance from July. See gross and operating margins to trend similarly in 2008 to what happened in 2007. Saying the next big jump is to high-definition online video. Trying to ease margin concerns by saying that they see overall volume increasing and that they are still commanding a premium for the solutions they offer. Saying they “are not even in spring training on online HD, its about to get going”. Saying growth is still primarily organic. When asked about competition: Saying that their 1000 networks give them a differentiated performance and scale that their customers recognize. Noting that most of the largest data transport networks don’t connect to any end users. Noting that they will go into more detail at their analyst day next week. Noting that growth rate is slowing from what they saw in ‘06. But reiterating that they see 25-30% growth in ‘08. Saying that PCI compliance, and how the online world adapts, will be a “gigantic question” for commerical sites and that business that bring PCI solutions to market will have an advantage. Saying peer-peer is not a long term solution… an add-on not a replacement. Noting that they are fairly picky about their customer adds as they want all of their customers to be successful so that they can be long-term profitable customers. Noting that they don’t see the slightly lower customer adds this qtr as a negative. Trading at $33.40 in after-hours
17:37 MDC MDC Holdings reports Q3 (Sep) results, misses on revs (40.81 +0.04)

Reports Q3 (Sep) loss of $3.40 per share, includes charges, may not be comparable to the Reuters Estimates consensus of ($1.46); revenues fell 36.5% year/year to $686.7 mln vs the $722 mln consensus.
17:35 GRT Glimcher Realty misses by $0.01; guides Q4 FFO’s below consensus (22.50 +0.14)

Reports Q3 (Sept) earnings of $0.50 per share, $0.01 worse than the Reuters Estimates consensus of $0.51; revenues rose 1.5% year/year to $75.3 mln vs the $66.9 mln consensus. Co issues downside guidance; co sees Q4 FFO’s of $0.65-0.71 vs $0.78 Reuters consensus.
17:34 MDC prelim ($3.40), may not be comparable to ($1.46) Reuters consensus; revs $686.7 mln vs $722.04 mln Reuters consensus

17:33 NKTR Nektar Therapeutics discloses additional details on termination of PFE Exubera agreement (6.58 -0.07)

From 8-K: “On October 18, 2007, Pfizer (PFE) delivered a notice of termination of the Collaborative Development and License Agreement by and between Nektar Therapeutics and Pfizer, dated January 18, 1995, and certain other ancillary agreements related thereto. Under the terms of the Pfizer Agreements, this termination is effective ninety (90) days from October 18, 2007. This termination by Pfizer was in connection with its public announcement on October 18, 2007, that Pfizer decided to exit Exubera, the inhaled insulin product that is the subject of the Pfizer Agreements. Nektar is evaluating its contractual rights and other options with respect to Pfizer’s termination of the Pfizer Agreements, including Pfizer’s performance under such agreements. Nektar is also evaluating its options with respect to the inhaled insulin franchise, including the potential for finding another partner for the commercialization of Exubera and/or the development of the second generation inhaled insulin program… We expect to incur significant charges and other wind-down expenses in connection with the termination of the Pfizer Agreements and estimates of such potential charges and expenses are not available at this time… The termination of the Pfizer Agreements also subjects Nektar to additional risks and costs, including: Nektar’s revenue and results of operations have historically depended on sales to Pfizer. Nektar’s total revenue from the Pfizer Agreements for the three-month and six-month periods ended June 30, 2007, was 66% and 72%, respectively, of Nektar’s total revenue for such three-month and six-month periods. As a result of the termination of the Pfizer Agreements, we anticipate that we will not continue to receive significant revenue from the commercial manufacture and sale of Exubera inhalers and inhalation powder to Pfizer. Accordingly, our revenues will decline significantly in future periods. In addition, because Pfizer had sole responsibility for the sales and marketing of Exubera, we are not in a position to commercialize Exubera on our own. Accordingly, we cannot predict sales of Exubera after the contract termination date.”
17:31 ULGX Urologix reports Q1 EPS of ($0.03) vs ($0.03) consensus; reports revs down 20% yr/yr to $4.4 mln vs $5.0 mln consensus (1.67 -0.06)

17:31 EGP sees Q4 funds from operations of $0.84-0.86 vs $0.79 Reuters consensus

17:30 ACMR prelim ($0.02) vs ($0.04) Reuters consensus; revs $122.6 mln vs $130.34 mln Reuters consensus

17:30 BAC Bank of America: Follow-up on 17:21 WSJ layoff headline (47.48 -0.30) -Update-

WSJ reports the co is poised to launch a major shakeup of its investment bank, including layoffs and the retirement of the head of its Global Corporate and Investment Banking unit, people familiar with the plan told The WSJ. A Bank of America executive confirmed the plan and said an official announcement was expected. Gene Taylor, president of the unit and a 38-veteran Bank of America executive, will retire, according to people familiar with the plan. The bank will also lay off about 3,000 employees, with the biggest hits coming in the investment banking unit, and begin a comprehensive strategic review of that line of business, those people said. Succeeding Taylor as head of the unit will be Brian Moynihan. Moynihan, in turn, will be replaced by Keith Banks, who runs the Columbia Management mutual funds arm, those people said. Moynihan told The WSJ the shakeup isn’t a wholesale retreat from investment banking but an effort to acknowledge weaknesses and begin rebuilding for the future. Moynihan said the bank will continues to be active in treasury mgmt, commercial lending, debt issuance and other key services for big commercial customers.
17:30 EGP prelim funds from operations of $0.80 vs $0.76 Reuters consensus; revs $39.2 mln vs $38.07 mln Reuters consensus

17:29 GRP sees Q4 $1.09-1.11 vs $1.12 Reuters consensus

17:29 GRP prelim $0.96 vs $0.97 Reuters consensus; revs $539.9 mln vs $547.58 mln Reuters consensus

17:27 HPC Hercules beats by $0.05 - correction (20.27 unch)

Reports Q3 (Sep) earnings of $0.46 per share, $0.05 better than the Reuters Estimates consensus of $0.41; revenues rose 6.1% year/year to $544.2 mln vs the $550.9 mln consensus. HPC remain confident in growth strategy and optimistic about both earnings and cash flow growth for the balance of the year and as they look to 2008.
17:27 FMCN Focus Media registers 13.7 mln ADS offering (57.47 -0.30) -Update-

FMCN discloses it is offering 5 mln American depositary shares, or ADSs, and the selling shareholders identified in this prospectus are offering an additional 8,720,873 ADSs. Each ADS represents five ordinary shares, par value $0.00005 per share of Focus Media. The ADSs may be evidenced by American depositary receipts, or ADRs. We will not receive any proceeds from the ADSs sold by the selling shareholders.
17:26 WSH Willis Group beats by $0.05, misses on revs (38.34 -0.26)

Reports Q3 (Sep) earnings of $0.46 per share, $0.05 better than the Reuters Estimates consensus of $0.41; revenues rose 5.7% year/year to $574 mln vs the $586.9 mln consensus. For the full year 2007, Willis expects to continue to grow organic revenue and expand adjusted operating margin modestly to approx 24%. The co expects to deliver breakout financial performance. Specifically, by the full year 2010, the Company has set financial targets of salaries and benefits expense as a percentage of total revenues to be below 54%, adjusted operating margin of 28% or better and industry leading organic revenue growth.
17:25 Indonesia hit by strong 7.0 earthquake off Sumatra, tsunami warning issued, according to local met agency - Reuters

17:24 VMW VMware on Conf Call notes that they will not be providing Q4 guidance; states not sure what type of guidance they will provide for Y08 (103.52 -2.63) -Update-

Stock trading at $110.55 in after hours.
17:23 MLNX Mellanox Tech: On Q3 call; co sees Q4 gross margins of 72-73% (22.54 -1.61) -Update-

17:23 QTM Quantum DLT earnings color (520.50 +1.60) -Update-

Reuters Estimates is telling us that excluding ADIC acquisition-related expenses and amortization of intangibles, an actual of $0.02 is comparable to their consensus of $0.02. See 16:44 comment for full report.
17:23 WSH prelim $0.46 vs $0.41 Reuters consensus, $0.40 First Call; revs $574 mln vs $586.93 mln Reuters consensus

17:21 MLNX Mellanox Tech: On Q3 call, co sees Q4 revs of $24 -24.5 mln vs $24.12 mln consensus (22.54 -1.61) -Update-

17:21 CMG Chipotle Mexican Grill will replace Bowater in the S&P MidCap 400 (123.55 -3.5

Chipotle Mexican Grill (CMG) will replace Bowater (BOW) in the S&P MidCap 400 after the close of trading on Friday, October 26. Bowater and Abitibi-Consolidated Inc. (ABY) are merging to form AbitibiBowater (ABH), in a deal that is expected to close on or about that date, pending final approvals. AbitibiBowater will not be added to the S&P 1500 at this time.
17:21 SMMX SYMYX Tech earnings color (10.11 -0.29) -Update-

Reuters Estimates is telling us that an actual of ($0.01) excluding gain from Symyx’s sale of its Ilypsa equity interest and including stock-based compensation expense and amortization of intangibles from previous acquisitions, is comparable to their consensus of ($0.03). See 17:05 comment for the full earnings report.
17:21 BAC Bank of America: Will layoff about 3,000 employees - WSJ (47.48 -0.30)

BAC to launch shakeup of investment bank ops - WSJ
17:20 BZP BPZ Energy announces plan for accelerated first oil production in Peru (10.34 +0.19)

Co announced that short term contracts have been finalized and signed with the commercial area of the Peruvian Navy to lease two tankers to transport oil to market earlier than scheduled. The two tankers leased from the Navy each have capacity of approximately 6,000 barrels. With the current production facilities and these two tankers, the Company expects to produce ~2,500 barrels of oil per day (bopd) beginning in early November barring any unforeseen circumstances.
17:17 BXP Boston Prpts beats by $0.04, beats on revs; guides Q4 EPS below consensus; guides FY08 EPS below consensus (104.15 -0.67)

Reports Q3 (Sep) funds from operations of $1.20 per share, excl $0.03 charge, $0.04 better than the Reuters Estimates consensus of $1.16; revenues rose 3.3% year/year to $371.5 mln vs the $338.8 mln consensus. Co issues downside guidance for Q4, sees FFO of $1.18 vs. $1.20 consensus. Co issues downside guidance for FY08, sees FFO of $4.62-4.72 vs. $4.76 consensus. Co also notes that Michael E. LaBelle has been promoted to Senior Vice President, Chief Financial Officer and Treasurer of the Co from Senior Vice President, Finance. Mr. LaBelle joined the Co in March 2000.
17:16 TEX Terex misses by $0.02, reports revs in-line; reaffirms prior FY07 guidance (82.93 +0.76)

Reports Q3 (Sep) earnings of $1.45 per share, $0.02 worse than the Reuters Estimates consensus of $1.47; revenues rose 15.4% year/year to $2.20 bln vs the $2.21 bln consensus. Co reaffirms prior guidance for FY07. Continues to see EPS of $5.50-5.70 vs. $5.70 consensus; sees FY07 revs of $8.8-9.0 bln vs. $8.92 bln consensus.
17:14 TEX sees FY07 $5.50-5.70 vs $5.70 Reuters consensus; sees revs $8.8-9.0 bln vs $8.92 bln Reuters consensus

17:13 TEX prelim $1.45 vs $1.47 Reuters consensus; revs $2.20 bln vs $2.21 bln Reuters consensus

17:11 CLB Core Labs beats by $0.03, misses on revs; guides Q4 EPS in-line, revs in-line; guides FY07 EPS above consensus; guides FY08 EPS in-line, revs below consensus (128.47 -0.97)

Reports Q3 (Sep) earnings of $1.29 per share, $0.03 better than the Reuters Estimates consensus of $1.26; revenues rose 16.9% year/year to $170.1 mln vs the $173.3 mln consensus. Co issues in-line guidance for Q4, sees EPS of $1.30-1.34 vs. $1.32 consensus; sees Q4 revs of $173-178 vs. $177.55 mln consensus. Co issues upside guidance for FY07, sees EPS of $4.81-4.85 vs. $4.79 consensus. Co issues mixed guidance for FY08, sees EPS of $5.75-6.00 vs. $5.96 consensus; sees FY08 revs of $737-757 mln vs. $772.63 mln consensus.
17:11 BXP sees FY08 funds from operations of $4.62-4.72 vs $4.76 Reuters consensus

17:11 AEM Agnico-Eagle Mines reports EPS in-line, misses on revs (51.88 -1.07)

Reports Q3 (Sep) earnings of $0.27 per share, excluding non-recurring items, in-line with the Reuters Estimates consensus of $0.27; revenues fell 3.7% year/year to $104.8 mln vs the $113 mln consensus. Earnings for the third quarter 2007 fell by approximately $10 mln, net of the translation loss, period over period. This was largely due to the impact of a stronger Canadian dollar on operating costs and lower realized byproduct zinc prices, offset partly by a higher gold price. Earnings per share were also diluted by the issuance of approximately 13.8 mln common shares upon the acquisition of Cumberland Resources Ltd. in 2007. Payable gold production in Q3 was 55,830 ounces at total cash costs per ounce of minus $307. This compares with payable gold production of 59,603 ounces, at total cash costs per ounce of minus $709, in 3Q06. On December 10, 2007, the 2008 production and cost forecast is expected to be announced. At this time, the co expects to provide an update on the six development projects including updated capital expenditure estimates incorporating more recent exchange rates. The Board of Directors is expected to make a decision regarding the 2007 dividend at that time. Exploration updates are also expected for several of the development projects prior to the February reserve and resource update.
17:11 BXP sees Q4 funds from operations of $1.18-1.19 vs $1.20 Reuters consensus

17:10 BXP prelim funds from operations of $1.20 vs $1.16 Reuters consensus, $345.53 First Call; revs $371.5 mln vs $338.83 mln Reuters consensus

17:07 GGG Graco beats by $0.03, misses on revs (38.30 +0.24)

Reports Q3 (Sep) earnings of $0.60 per share, $0.03 better than the Reuters Estimates consensus of $0.57; revenues rose 2.5% year/year to $207.3 mln vs the $212.9 mln consensus. GGG says “We are optimistic about continued strength in our international businesses this year and remain cautious in our outlook for sales this year and remain cautious in our outlook for sales.
17:05 ACXM Acxiom beats by $0.05, misses on revs; guides FY08 EPS in-line (14.17 +0.75)

Reports Q2 (Sep) earnings of $0.17 per share, excluding non-recurring items, $0.05 better than the Reuters Estimates consensus of $0.12; revenues rose 0.8% year/year to $351 mln vs the $355.6 mln consensus. Co issues upside guidance for FY08, sees EPS of $0.91-0.95, excluding non-recurring items, vs. $0.83 consensus; co sees revs flat to +1%. Previous guidance issued under the Financial Road Map should no longer be relied upon.
17:05 PSSI PSS World Med Earnings Color (18.50 +0.01) -Update-

Reuters Estimates is telling us that, excluding 0.01 per diluted share for temporary operational costs ssociated with new Florida pedigree law; $0.01 per diluted share to increase accrual for destruction of pedigree-related quarantined inventory; $0.01 per diluted share of integration costs for the Activus acquisition; $0.04 per diluted share reduction of accruals for management incentive programs, an actual of $0.21 per share is comparable to Reuters estimates of $0.20. See earlier comment at 16:47.
17:05 SMMX SYMYX Tech reports Q3 (Sep) results, revs in-line; guides Q4 revs above consensus (10.11 -0.29)

Reports Q3 (Sep) earnings of $0.73 per share, includes multiple charges and gains, not comparable to the Reuters Estimates consensus of ($0.03); revenues fell 11.6% year/year to $26.1 mln vs the $26.2 mln consensus. Co sees Q4 revs of $40-46 mln vs. $34.35 mln consensus; sees EPS od $0.30-0.38, does not comapre to consensus of $0.08.
17:03 MUR Murphy Oil beats by $0.09, beats on revs; guides Q4 EPS below consensus (77.05 +1.37)

Reports Q3 (Sep) earnings of $1.04 per share, $0.09 better than the Reuters Estimates consensus of $0.95; revenues rose 15.1% year/year to $4.78 bln vs the $4.63 bln consensus. Co issues downside guidance for Q4, sees EPS of $0.75-1.00 vs. $1.09 consensus.
17:03 RCRC RC2 Earnings Color (28.55 -0.26) -Update-

Reuters Estimates is telling us that, excluding $9.4 million of recall-related costs, an actual of $0.80 per share is comparable to Reuters estimates of $0.71. See earlier comment at 16:27.
17:02 FORM FormFactor: On conf call, co guides Q4 EPS to $0.40-0.44 vs 0.43 consensus; guides revs to $123-128 mln vs $131.62 mln consensus… stock trading at $39.00 (43.24 -0.2 -Update-

17:02 CLF Cleveland-Cliffs completes longwall move at Pinnacle Mine, updates 2007 met coal production forecast (97.89 +0.70)

The co announces “that it has resumed normal production at its Pinnacle Mine in Pineville, W. Va., after completing the move of its longwall plow system. Production at Pinnacle slowed in August as a result of sandstone intrusions encountered within the coal panel being mined at the time. This slowdown prompted the decision last month to move the mine’s longwall plow system to another panel. As a result of completing the longwall move, Cliffs updated its total metallurgical coal production forecast for all three of its U.S. metallurgical coal mines–Pinnacle, Green Ridge and Oak Grove–to 1.1 mln tons for the last five months of 2007, compared with a previous forecast of 2 mln tons.”
17:02 IGTE iGATE reports EPS in-line, misses on revs (9.91 +0.02)

Reports Q3 (Sep) earnings of $0.08 per share, in-line with the Reuters Estimates consensus of $0.08; revenues rose 5.7% year/year to $76.1 mln vs the $77.7 mln consensus.
17:01 MUR sees Q4 $0.75-1.00 vs $1.09 Reuters consensus

17:01 PHRM Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference (48.29 -0.36)

In summary, of the 13 evaluable patients there was one partial response (PR - RECIST criteria, unidimensional greater than or equal to 30% shrinkage) and eight stable disease (SD). In addition, five of the 13 evaluable patients experienced tumor shrinkage. The PR and a near PR (SD with 29% tumor shrinkage) were observed in pancreatic cancer patients, both of whom remain on study having received six and three cycles of treatment, respectively. Importantly, of the four evaluable patients with pancreatic cancer, there was one PR and three SD, which includes the one near PR.
17:01 GGG says “We are optimistic about continued strength in our international businesses this year and remain cautious in our outlook for sales this year and remain cautious in our outlook for sales

17:01 AEM prelim $0.27 vs $0.27 Reuters consensus, $0.26 First Call; revs $104.8 mln vs $113.00 mln Reuters consensus, $120.00 mln First Call

17:00 MUR prelim $1.04 vs $0.95 Reuters consensus; revs $4.78 bln vs $4.63 bln Reuters consensus

17:00 IGTE prelim $0.08 vs $0.08 Reuters consensus; revs $76.1 mln vs $77.69 mln Reuters consensus

17:00 GGG prelim $0.60 vs $0.57 Reuters consensus; revs $207.3 mln vs $212.93 mln Reuters consensus

16:59 CPWR Compuware beats by $0.08, beats on revs (8.81 +0.07)

Reports Q2 (Sep) earnings of $0.17 per share, excluding non-recurring items, $0.08 better than the Reuters Estimates consensus of $0.09; revenues rose 4.7% year/year to $302 mln vs the $284.7 mln consensus.
16:58 FNF Fidelity National misses by $0.01, misses on revs (15.93 -0.62)

Reports Q3 (Sep) earnings of $0.28 per share, excluding non-recurring items, $0.01 worse than the Reuters Estimates consensus of $0.29; revenues fell 48.1% year/year to $1.36 bln vs the $1.42 bln consensus.
16:58 RYL Ryland Group reports Q3 (Sep) results, misses on revs (26.26 +0.77)

Reports Q3 (Sep) loss of $1.30 per share, includes multiple items, may not be comparable to the Reuters Estimates consensus of ($0.57); revenues fell 35.2% year/year to $732.3 mln vs the $790.4 mln consensus.
16:58 CPWR Compuware beats by $0.08, beats on revs (8.81 +0.07)

Reports Q2 (Sep) earnings of $0.17 per share, excluding restructuring charges, $0.08 better than the Reuters Estimates consensus of $0.09; revenues rose 4.7% year/year to $302 mln vs the $284.7 mln consensus.
16:57 AGP Amerigroup beats by $0.06, beats on revs; guides FY07 EPS in-line; guides FY08 EPS above consensus (33.24 -1.9

Reports Q3 (Sep) earnings of $0.58 per share, $0.06 better than the Reuters Estimates consensus of $0.52; revenues rose 45.7% year/year to $1.03 bln vs the $1.02 bln consensus. AGP sees Y07 organic premium rev growth of approx 37%, compared to previous guidance of 35%. Co issues in-line guidance for FY07, sees EPS of $2.12-2.14 vs. $2.07 consensus up from previous $2.00 to $2.10. Co issues upside guidance for FY08, sees EPS of $2.45-2.60 vs. $2.35 consensus.
16:55 MTSN Mattson misses by $0.02, misses on revs; guides Q4 EPS in-line, revs below consensus (8.96 -0.11)

Reports Q3 (Sep) earnings of $0.04 per share, excluding non-recurring items, $0.02 worse than the Reuters Estimates consensus of $0.06; revenues fell 32.4% year/year to $58.5 mln vs the $61.1 mln consensus. Co’s Board of Directors has authorized an additional $30 million share repurchase. Co issues mixed guidance for Q4, sees EPS of ($0.06)-$0.05 vs. $0.05 consensus; sees Q4 revs of $45-55 mln vs. $58.86 mln consensus; co sees bookings of $50-60 mln.
16:55 KERX Keryx Biopharma beats by $0.02 (10.20 -0.10)

Reports Q3 (Sep) loss per share of ($0.45), $0.02 better than the Reuters Estimates consensus of ($0.47), on revs of $52K vs consensus of $90K.
16:54 CDNS Cadence Design beats by $0.01, reports revs in-line; guides Q4 EPS in-line, revs in-line (21.69 -0.19)

Reports Q3 (Sep) earnings of $0.33 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.32; revenues rose 9.6% year/year to $401 mln vs the $401.3 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.45-0.47, excluding non-recurring items, vs. $0.46 consensus; sees Q4 revs of $465-475 mln vs. $468.66 mln consensus.
16:54 LSI LSI Logic beats by $0.05, beats on revs; guides Q4 EPS, revs in-line (7.09 -0.19)

Reports Q3 (Sep) earnings of $0.06 per share, excluding non-recurring items, $0.05 better than the Reuters Estimates consensus of $0.01; revenues rose 47.5% year/year to $727 mln vs the $691.4 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.05-0.09 vs. $0.05 consensus; sees Q4 revs of $700-730 mln vs. $723.07 mln consensus. “Our solid quarterly results were driven by strong end customer demand in our storage and networking businesses and by achieving substantial cost reductions during our second full quarter of combined operations with Agere… As a more focused company, we are now experiencing a significantly higher level of engagement with our customers and substantial increases in design win opportunities… We experienced healthy demand in both our semiconductor and storage systems segments, with double-digit sequential revenue growth in storage and networking semiconductors. Our continuing focus on driving organizational efficiencies and maintaining tight controls contributed to significantly lower operating expenses and improved margins.”
16:53 QDEL Quidel beats by $0.01, reports revs in-line (18.52 -0.31)

Reports Q3 (Sep) earnings of $0.07 per share, $0.01 better than the Reuters Estimates consensus of $0.06; revenues rose 16.5% year/year to $27.6 mln vs the $27.5 mln consensus.
16:52 KERX prelim ($0.45) vs ($0.47) Reuters consensus; revs $52K vs $90K Reuters consensus

16:52 CVD Covance beats by $0.01, beats on revs; guides FY07 EPS above consensus (79.17 +1.24)

Reports Q3 (Sep) earnings of $0.69 per share, $0.01 better than the Reuters Estimates consensus of $0.68; revenues rose 16.0% year/year to $396 mln vs the $392 mln consensus. Co issues upside guidance for FY07, sees EPS of $2.65 vs. $2.64 consensus. “Looking forward to 2008, based upon our strong performance again this quarter and our expanding backlog, we are again targeting revenue growth in the low- to mid-teens range and diluted earnings per share growth of 20%.”
16:52 PCTI PC-TEL beats by $0.02, beats on revs (7.86 -0.09)

Reports Q3 (Sep) earnings of $0.11 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.09; revenues fell 1.0% year/year to $20.3 mln vs the $19.9 mln consensus.
16:51 TQNT TriQuint Semi beats by $0.02, beats on revs; guides Q4 EPS in-line, revs in-line (4.62 -0.20)

Reports Q3 (Sep) earnings of $0.08 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.06; revenues rose 19.0% year/year to $122.9 mln vs the $116.5 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.08-0.10 vs. $0.09 consensus; sees Q4 revs of $125-130 mln vs. $126.08 mln consensus.
16:51 ACLI American Commercial Lines misses by $0.16, misses on revs; guides FY07 EPS below consensus (19.78 -0.59)

Reports Q3 (Sep) earnings of $0.30 per share, $0.16 worse than the Reuters Estimates consensus of $0.46; revenues fell 3.1% year/year to $258.4 mln vs the $296.7 mln consensus. Co issues downside guidance for FY07, sees EPS of $0.74, including $0.26 in charges, vs. $1.34 consensus. Co says “We are seeing sequential improvement in our quarterly manufacturing performance on all barges produced. This performance confirms the manufacturing business is recovering and is poised to benefit from changes that occurred during the past twelve months - a 35% increase in production, a 20% increase in the workforce and the completion of major capital projects.”
16:51 NUVA NuVasive beats by $0.03, beats on revs; guides FY07 EPS above consensus, revs above consensus (38.51 +0.26)

Reports Q3 (Sep) loss of $0.06 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of ($0.09); revenues rose 52.8% year/year to $38.5 mln vs the $36.3 mln consensus. Co issues upside guidance for FY07, sees EPS of $(0.27)-(0.31), excluding non-recurring items, vs. ($0.35) consensus; sees FY07 revs of $147-148 mln, compared to previous guidance of $143-146 mln, vs. $145.59 mln consensus.
16:51 EXTR Extreme Networks beats by $0.02, beats on revs (3.64 -0.07)

Reports Q1 (Sep) earnings of $0.04 per share, excluding non-recurring items, $0.02 better than the Reuters Estimates consensus of $0.02; revenues rose 6.2% year/year to $89 mln vs the $87.9 mln consensus. Co says “We are pleased to see a continuation of our turnaround this quarter, with substantial improvement to operating margins, and with revenue up both sequentially and yr-over-yr to a level we have not seen since Dec 2005.”
16:50 SSCC Smurfit-Stone beats by $0.01, misses on revs (13.20 -0.11)

Reports Q3 (Sep) earnings of $0.11 per share, $0.01 better than the Reuters Estimates consensus of $0.10; revenues rose 2.5% year/year to $1.89 bln vs the $1.92 bln consensus. The co also said “While the co expects significant price improvement in the fourth quarter, earnings will likely decrease sequentially due to seasonal and timing factors. Results will be impacted by significant additional mill maintenance downtime and associated costs, higher energy usage and wood fiber costs, and the impact from the Brewton mill sale. Commenting on the co’s outlook, Moore said, “Despite slightly lower anticipated fourth quarter earnings, we remain on track to achieve our longer term objectives. Our strategic initiatives program is on schedule to reduce costs $525 mln by the end of 2008. These efforts, along with our $400 mln incremental capital program, should drive continued margin and efficiency improvements at Smurfit-Stone….”
16:50 NETL NetLogic beats by $0.05, beats on revs (34.79 -0.41)

Reports Q3 (Sep) earnings of $0.34 per share, $0.05 better than the Reuters Estimates consensus of $0.29; revenues rose 6.6% year/year to $27.5 mln vs the $27 mln consensus.
16:49 LSI sees Q4 $0.05-0.09 vs $0.05 Reuters consensus; sees revs $700-730 mln vs $723.07 mln Reuters consensus

16:49 FIS Fidelity National Information Services misses by $0.02, misses on revs; guides FY07 EPS in-line (46.65 -0.45)

Reports Q3 (Sep) earnings of $0.63 per share, excluding non-recurring items, $0.02 worse than the Reuters Estimates consensus of $0.65; revenues rose 10.4% year/year to $1.17 bln vs the $1.19 bln consensus. Co issues guidance for FY07, sees EPS of at low end of previous $2.44-2.50 range vs. $2.48 consensus. eFunds is excpected to be neutral to 2007 cash earnings per diluted share.
16:49 LSI prelim $0.06 vs $0.01 Reuters consensus; revs $727 mln vs $691.39 mln Reuters consensus

16:49 MRCY Mercury Computer beats by $0.18, beats on revs; guides Q2 EPS above consensus, revs below consensus; guides FY08 EPS above consensus, revs above consensus (10.88 -0.5

Reports Q1 (Sep) earnings of $0.09 per share, $0.18 better than the Reuters Estimates consensus of ($0.09); revenues rose 0.5% year/year to $49.2 mln vs the $47.5 mln consensus. Co issues mixed guidance for Q2, sees EPS of $0.05 vs. ($0.03) consensus; sees Q2 revs of $51 vs. $53.37 mln consensus. Co issues upside guidance for FY08, sees EPS of $0.33 vs. $0.10 consensus; sees FY08 revs of $225 vs. $222.42 mln consensus. “The results for the first quarter are very encouraging. They demonstrate that the operational effectiveness initiatives we began implementing several quarters ago in conjunction with the restructuring of the organization, cost reduction initiatives and personnel changes are beginning to show the desired results.”
16:48 EGR Commerce Energy reports FY07 EPS of $0.03 vs $0.02 yr ago; revs rise 50% to $371.6 mln (2.15 +0.01)

16:48 MRH Montpelier Re beats by $0.21 (17.04 +0.02)

Reports Q3 (Sep) earnings of $0.82 per share, $0.21 better than the Reuters Estimates consensus of $0.61. At September 30, 2007, the co held $19.0 mln of securities with exposure to the sub-prime mortgage market with an estimated weighted average life of 1.9 years and $63.7 mln of securities with exposure to the Alternative-A mortgage market with an estimated weighted average life of 3.4 years. All of these securities are currently rated AAA and are carried at fair value. Co reported a fully converted book value per share of $17.03 as at September 30, 2007, an increase of 6.6% for the quarter inclusive of dividends.
16:47 PSSI PSS World Med beats by $0.09, misses on revs; guides FY08 EPS in-line (18.50 +0.01)

Reports Q2 (Sep) earnings of $0.29 per share, excluding costs associated with new Florida pedigree law, costs for the Activus acquisition, and accruals, $0.09 better than the Reuters Estimates consensus of $0.20; revenues were unchanged from the year-ago period at $427.1 mln. Co issues reaffirms guidance for FY08, sees EPS of $0.81-0.85 vs. $0.82 consensus. Co also reaffirms FY07 cash flow from operations of $63 - $67 mln.
16:46 F Ford readying new round of buyouts, according to sources - Reuters (8.59 -0.06) -Update-

Reuters reports the co and the United Auto Workers union have agreed on the broad terms of a new round of buyouts that would slash thousands of jobs under the terms of a new contract, people familiar with the ongoing talks said.
16:45 DAIO Data I/O reports Q3 EPS of $0.19, ex $0.01 charge, vs $0.02, excl $0.01, yr ago; revs rise 26% to $7.3 mln (4.02 +0.04)

16:44 QTM Quantum DLT reports Q2 (Sep) results, misses on revs (520.50 +1.60)

Reports Q2 (Sep) earnings of $0.04 per share, excludes charges, but also excluding stock based compensation that analysts are including, may not be comparable to the Reuters Estimates consensus of $0.02; revenues fell 0.8% year/year to $248.5 mln vs the $260.3 mln consensus.
16:44 AKAM Akamai Tech Guiding FY07 EPS $1.28-$1.29 on $625-629 mln (32.97 ) -Update-

Consensus is for EPS $1.27 on $625.4 mln in revs
16:43 FORM FormFactor doesn’t report EPS due to to inventory valuations review; reports revs of $125.3 mln; doesn’t expect EPS to be less than $0.38-0.40 for Q3 (43.24 -0.2 -Update-

Co said it is unable at this time to release further income statement data with respect to the third quarter. The Company is currently reviewing its historic practices with respect to inventory valuation in light of issues identified by the Company in the course of preparation of financial statements for the third quarter. Based on the review to date management believes that adjustments to inventory valuations may be required with respect to periods prior to the third quarter of 2007. These potential adjustments could change inventory, gross margin, operating margin and net income from the amounts previously reported for the affected periods. The Company has not yet determined the magnitude of these adjustments or whether the adjustments will be reflected in the third quarter financial statements or in a restatement of the affected periods. The Company believes, however, that its third quarter operating margin and net income per share, without giving effect to adjustments in respect of prior periods, should be not less than the 20.5%-21% and $0.38-$0.40 (consensus $0.39). Co also reported revs of $125.3 mln (consensus $125.57 mln).
16:43 ATX A.T. Cross Company reports Q3 EPS of $0.15 vs $0.02 yr ago; revs rise 10% to $35.1 mln (11.50 +0.40)

16:43 OCNF Oceanfreight misses on EPS, but beats on revs (30.00 -0.45) -Update-

Reports Q3 (Sep) earnings of $0.11 per share, $0.07 worse than the Reuters Estimates consensus of $0.18; Co reports revenue of $15.8 mln vs the $14.5 mln consensus. Co had no revenue in Q3 2006 as it’s a newly formed company.
16:43 FFIV F5 Networks earnings color (40.47 -3.80) -Update-

Reuters Estimates is telling us that an actual of $0.15, including in-process research and development expenses, is comparable to their consensus of $0.10. See 16:23 comment for the full earnings report.
16:43 CFC Countrywide announces change to Board of Directors (13.83 -1.22) -Update-

Co announces that Henry G. Cisneros has relinquished his Board of Director membership. Cisneros is chairman of CityView, a co that provides financing for America’s urban homebuilders. “I need to focus my time and energies on putting CityView in the best position to adjust to the demands of the period ahead,” Cisneros said.
16:42 LLY Eli Lilly halts 2 studies of blood-clotting drug - WSJ (56.15 -0.9 -Update-

WSJ reports the co is halting two small studies of the most promising drug in its pipeline, raising questions about a blood-thinning therapy the company hopes will bring in well over $1 bln a year in sales for the Indianapolis drug maker.
16:42 CBMX CombiMatrix reports Q3 EPS of ($0.57); revs rise 26% to $1.7 mln (6.49 +0.09)

16:41 CYBI Cybex misses by $0.02, misses on revs (4.62 -0.2

Reports Q0 earnings of $0.01 per share, excluding non-recurring items, $0.02 worse than the Reuters Estimates consensus of $0.03; revenues rose 9.0% year/year to $32.6 mln vs the $34.1 mln consensus.
16:41 ROMA Roma Financial announces stock repurchase program for up to 441,880 shares (5% of oustanding shares) (17.33 -0.41)

16:40 FADV First Advantage beats by $0.03, misses on revs (18.56 -0.60)

Reports Q3 (Sep) earnings of $0.34 per share, excluding charges, $0.03 better than the Reuters Estimates consensus of $0.31; revenues rose 3.5% year/year to $219.4 mln vs the $225.1 mln consensus.
16:40 ZMH Zimmer Hldgs reports EPS in-line, revs in-line; guides Q4 EPS below consensus, revs below consensus; guides FY07 EPS below consensus, revs below consensus (79.37 -0.09)

Reports Q3 (Sep) earnings of $0.91 per share, in-line with the Reuters Estimates consensus of $0.91; revenues rose 10.1% year/year to $903 mln vs the $907.7 mln consensus. Co issues downside guidance for Q4, sees EPS of $1.03-1.05 vs. $1.16 consensus; sees Q4 revs of $1.027-1.032 bln vs. $1.04 bln consensus. Co issues downside guidance for FY07, sees EPS of $3.91-3.93 vs. $4.03 consensus; sees FY07 revs of $3.851-3.856 bln vs. $3.87 bln consensus.
16:40 GSIC GSI Commerce beats by $0.03, misses on revs; issues downside Q4 rev guidance

Reports Q3 (Sep) loss of $0.10 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of ($0.13); revenues rose 15.9% year/year to $137.3 mln vs the $139.4 mln consensus. Co issues downside guidance for Q4, sees Q4 revs of $320-340 mln vs. $339.13 mln consensus.
16:40 WHG Westwood Hldgs reports Q3 EPS of $0.27; revs rise 27% (39.33 +1.27)

Reports Q3 (Sep) earnings of $0.27 per share (no estimates); revenues rose 27% year/year to $8.7 bln.
16:39 AMP Ameriprise Financial reports in-line (65.80 +0.39)

Reports Q3 (Sept) earnings of $0.99 per share, excluding non-recurring items, in-line with the Reuters Estimates consensus of $0.99; revenues rose 11.0% year/year to $2.2 bln vs the $2.2 bln consensus.
16:39 STR Questar beats by $0.10, misses on revs; guides FY07 EPS above consensus; guides FY08 EPS below consensus (52.06 +0.06)

Reports Q3 (Sep) earnings of $0.64 per share, $0.10 better than the Reuters Estimates consensus of $0.54; revenues fell 10.4% year/year to $497.4 mln vs the $584.5 mln consensus. Co issues upside guidance for FY07, sees EPS of $2.75-2.80, compared to previous guidance of $2.60-2.68, vs. $2.73 consensus. Co issues downside guidance for FY08, sees EPS of $2.85-3.00 vs. $3.03 consensus. Co sees Y07 Questar E&P production to range from 136-137 Bcfe, compared to previous guidance of 135-138 Bcfe; co sees Y07 NYMEX gas price per MMBtu of $7.00-7.50, compared to previous guidance of $6.50-7.50. Co sees Y08 Questar E&P production to range from 146-150 Bcfe with NYMEX gas price per MMBtu of $7.50-8.50.
16:38 EXBD Corp Exec Bd beats by $0.07, reports revs in-line; guides Q4 EPS in-line (76.42 +0.27)

Reports Q3 (Sep) earnings of $0.59 per share, $0.07 better than the Reuters Estimates consensus of $0.52; revenues rose 15.1% year/year to $136.3 mln vs the $137.6 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.59-0.64 vs. $0.62 consensus.
16:38 TXCC TranSwitch reports Q3 net loss of ($0.03), includes items, may note be comparable to ($0.03) Reuters consensus; revs fell 24% YoY to $7.23 mln vs $7.30 mln Reuters consensus (1.00 +0.02)

Co reports a Q3 net loss of ($0.03), includes items, may note be comparable to ($0.03) Reuters consensus; revs fell 24% YoY to $7.23 mln vs $7.30 mln Reuters consensus. Co is projecting Q4 revenue to be in the range of $7.2-$7.5 mln. Our 4Q07 net loss is estimated to be roughly $(0.04) per basic and diluted common share.
16:37 LOOP Loopnet beats by $0.02, beats on revs; guides Q4 EPS in-line, revs in-line; guides FY07 EPS above consensus, revs above consensus (21.92 -0.3

Reports Q3 (Sep) earnings of $0.14 per share, $0.02 better than the Reuters Estimates consensus of $0.12; revenues rose 46.5% year/year to $18.6 mln vs the $17.9 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.11-0.12 vs. $0.12 consensus; sees Q4 revs of $18.9-19.1 mln vs. $18.78 mln consensus. Co issues upside guidance for FY07, sees EPS of $0.49-0.50 vs. $0.47 consensus; sees FY07 revs of $70.1-70.3 mln vs. $69.23 mln consensus.
16:37 IRBT IRobot misses by $0.02, reports revs in-line; guides FY07 revs above consensus (15.46 -0.34)

Reports Q3 (Sep) loss of $0.06 per share, $0.02 worse than the Reuters Estimates consensus of ($0.04); revenues rose 16.0% year/year to $63.8 mln vs the $63.6 mln consensus. Co issues upside guidance for FY07, sees FY07 revs of $240-250 mln vs. $237.3 mln consensus.
16:36 ZMH sees FY07 $3.91-3.93 vs $4.03 Reuters consensus; sees revs $3.851-3.856 bln vs $3.87 bln Reuters consensus

16:36 ZMH sees Q4 $1.03-1.05 vs $1.16 Reuters consensus; sees revs $1.027-1.032 bln vs $1.04 bln Reuters consensus

16:36 ESIO Electro Scientific reports Q2 EPS of $0.19 vs $0.30 consensus; revs of $82.3 mln vs $89.6 mln consensus (22.05 -0.94) -Update-

“In addition to achieving the highest quarterly shipment and revenue results since 2001, we recorded the highest order level since the fourth quarter of 2004. Our interconnect segment reported the second consecutive record breaking quarter for orders and the passive component group achieved the highest order levels since 2001. In our semiconductor segment, we received multiple orders for our newest memory repair system, the 9850 UV. In late July, we concluded the purchase of NWR and the partial quarter results from this acquisition contributed to the strong success of the quarter.”
16:35 IDTI Integrated Device beats by $0.02, reports revs in-line; announces $200 mln expansion of repurchase program (13.36 -0.50)

Reports Q2 (Sep) earnings of $0.25 per share, $0.02 better than the Reuters Estimates consensus of $0.23; revenues rose 2.6% year/year to $204.1 mln vs the $204.3 mln consensus. Co also anounced $200 mln expansion of common stock repurchase program.
16:35 BBSI Barrett Business misses by $0.03, reports revs in-line; guides Q4 EPS below consensus, revs below consensus (22.56 -0.67)

Reports Q3 (Sep) earnings of $0.54 per share, $0.03 worse than the Reuters Estimates consensus of $0.57; revenues rose 8.4% year/year to $296.8 mln vs the $297.6 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.45-0.48 vs. $0.55 consensus; sees Q4 revs of $285-290 mln vs. $297.28 mln consensus.
16:35 ESRX Express Scripts beats by $0.03, misses on revs; raises FY07 EPS guidance (57.37 -1.03)

Reports Q3 (Sep) earnings of $0.60 per share, excluding non-recurring charges, $0.03 better than the Reuters Estimates consensus of $0.57; revenues rose 4.4% year/year to $4.52 bln vs the $4.58 bln consensus. Co raises their guidance for FY07, sees EPS of $2.28-2.32 vs. $2.28 consensus up from previous guidance of $2.23-2.29.
16:34 ZMH prelim $0.91 vs $0.91 Reuters consensus; revs $903.0 mln vs $907.68 mln Reuters consensus

16:34 PXLW Pixelworks beats by $0.01, beats on revs; guides Q4 EPS in-line, revs below consensus (1.28 -0.02)

Reports Q3 (Sep) loss of $0.02 per share, $0.01 better than the Reuters Estimates consensus of ($0.03). Co issues mixed guidance for Q4, sees EPS of $0.02-(0.03) vs. ($0.03) consensus; sees Q4 revs of $25-27 vs. $27.75 mln consensus.
16:34 MCRI Monarch Casino & Resort beats by $0.03, beats on revs (29.49 -0.7

Reports Q3 (Sep) earnings of $0.41 per share, $0.03 better than the Reuters Estimates consensus of $0.38; revenues rose 4.6% year/year to $43.6 mln vs the $41.8 mln consensus.
16:33 IRBT sees FY07 revs $240-250 mln vs $237.3 mln Reuters consensus

16:33 ARRS Arris reports EPS in-line, misses on revs; guides Q4 EPS in-line, revs in-line (12.13 -0.11)

Reports Q3 (Sep) earnings of $0.21 per share, excluding non-recurring items, in-line with the Reuters Estimates consensus of $0.21; revenues rose 11.4% year/year to $254.7 mln vs the $258 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.20-0.23, excluding $0.02 expense vs. $0.22 consensus; sees Q4 revs of $250-265 mln vs. $257.82 mln consensus.
16:32 NETL prelim $0.34 vs $0.29 Reuters consensus; revs $27.5 mln vs $27.04 mln Reuters consensus

16:32 CNS Cohen & Steers beats by $0.06, beats on revs (38.00 +0.50)

Reports Q0 earnings of $0.46 per share, excluding non-recurring items, $0.06 better than the Reuters Estimates consensus of $0.40; revenues rose 28.7% year/year to $69.5 mln vs the $68.3 mln consensus.
16:32 MTXX Matrixx Initiatives reports Q2 net of 0.63 vs 0.80 consensus; revs fell 16% to $28.6 mln vs $35.63 mln consensus (17.10 -0.66)

For fiscal 2008, the Company continues to anticipate annual net sales will increase 5-15% over the $97.6 million recorded for the trailing twelve months ended March 31, 2007. The Company also expects net income for fiscal 2008 will increase to the range of $9.3 million to $10.8 million.
16:32 GDI Gardner Denver beats by $0.05, beats on revs; guides Q4 EPS above consensus; guides FY08 EPS below consensus (37.64 +0.00)

Reports Q3 (Sep) earnings of $0.80 per share, excluding tax benefit, $0.05 better than the Reuters Estimates consensus of $0.75; revenues rose 10.4% year/year to $457.2 mln vs the $450.4 mln consensus. Co issues upside guidance for Q4, sees EPS of $0.87-0.92 vs. $0.79 consensus. Co issues downside guidance for FY08, sees EPS of $3.15-3.35 vs. $3.37 consensus.
16:32 SUMRX End of Day Summary

Some disappointing earnings developments, a weak existing home sales report, and a spike in oil prices precipitated a sharp decline in the major indices in the early-going. A late-day rally, however, made things look a lot better by the closing bell than they had been… Once again, there was a host of companies reporting quarterly results. The two reports that drew the most attention, and which were most responsible for the early declines, were the ones from Amazon.com (AMZN 88.73, -12.09) and Merrill Lynch (MER 63.22, -3.90)… In the case of Amazon, it actually beat the consensus EPS estimate by a penny and issued in-line guidance. With shares of AMZN up 49% from their July low, though, momentum accounts wanted more and sold the stock aggressively when they didn’t get it. In turn, underlying concerns about Amazon’s profit margins also drove the selling interest… The strikingly negative response to Amazon’s report got the better of a lot of high-flying technology stocks, as investors moved to secure profits. Those losses weighed heavily on the broader market and culminated in a 79-point drop for the Nasdaq Composite at its lows for the session… The Dow and S&P suffered considerably, too, with declines of 205 points and 30 points, respectively, at their worst levels. A dreadful third quarter report from Merrill Lynch, which posted a net loss of $2.85 per share from continuing operations after recording a massive $7.9 billion write-down for collateralized debt obligations and U.S. subprime mortgages, served as a driving catalyst… Merrill Lynch’s stock held up reasonably well initially, but when the news hit that Standard & Poor’s cut its debt ratings for the investment bank, and noted a negative outlook, losses in the stock accelerated… The financial sector (-0.8%) was taken along for the ride on pressing concerns that Merrill’s bad news suggests more write-downs will be coming in the fourth quarter. In brief, the realization hit that the third quarter may not have been the bottom for the financial sector as many pundits had claimed… Compounding the selling activity was the indication from the National Association of Realtors that existing home sales fell 8.0% in September to an annualized rate of 5.04 million units (consensus 5.25 mln) while median prices dropped 4.2%… Soon after the existing home sales report, the Dept. of Energy’s inventory report showed sharp declines in stockpiles versus the market’s expectations for a build in inventory levels. The surprising drawdown led to a 2.2% increase in crude prices to $87.10 per barrel… After suffering the early pounding, the stock market attempted to recover the lost ground in halfhearted fashion. The initial recovery try failed and the indices eventually rolled over again. However, when the indices retested their early morning lows around 2:00 pm ET and held, buyers stampeded back into the market and drove the Dow back to positive territory an hour later… The successful rebound effort most likely prompted some short-covering activity that contributed to the expeditious recovery… Separately, there was some speculation that the Fed might be on the verge of cutting the discount rate, but a Fed spokesman declined to comment on that speculation. Even so, the prospect of further rate cuts and the successful retest of the morning lows were motivating factors that spurred the renewed buying interest… The Treasury market for its part benefited from the stock market’s volatility and the weak housing data. The 10-year note gained a half point and saw its yield drop to 4.34%.
16:32 BSMD BioSphere Medical reports Q3 EPS of ($0.03) vs ($0.04) Reuters consensus; revs rose 18% YoY to $6.6 mln vs $7.01 mln Reuters consensus (5.05 -0.01)

16:31 IRBT prelim ($0.06) vs ($0.04) Reuters consensus; revs $63.8 mln vs $63.6 mln Reuters consensus

16:31 SSCC notes Q4 earnings will likely decrease sequentially due to seasonal and timing factors

16:31 BLL Ball Corp: Announces plant closures (53.05 -0.30)

The co announces “that it plans to close two aerosol container manufacturing plants in the United States and will exit the custom and decorative tinplate can business as part of a restructuring of the co’s metal food and household products packaging division, Americas. Ball plans to close aerosol can manufacturing plants in Commerce, Calif., and Tallapoosa, Ga., and relocate related aerosol container manufacturing equipment into existing metal food container facilities. Ball makes custom and decorative tinplate cans in its Baltimore plant, and intends to sell that facility. The co will record a largely noncash, after-tax charge of approximately $26 mln in the fourth quarter of 2007 related to the plant closures and equipment relocation. When completed in 2009, the actions are expected to yield annualized cost savings in excess of $15 mln. “
16:31 PCTI prelim $0.11 vs $0.09 Reuters consensus; revs $20.3 mln vs $19.89 mln Reuters consensus

16:31 CNS prelim $0.46 vs $0.40 Reuters consensus; revs $69.5 mln vs $68.31 mln Reuters consensus

16:30 SSCC prelim $0.11 vs $0.10 Reuters consensus; revs $1.89 bln vs $1.92 bln Reuters consensus

16:30 PSUN Pacific Sunwear to explore strategic alternatives for its demo stores; announces plans to close its 1000 Step stores (15.42 +0.0

The co announces “that it will explore strategic alternatives for the co’s demo stores and close its One Thousand Steps stores. The determination to take these actions resulted from a comprehensive review and evaluation of the real estate portfolio and profit performance of the co’s demo and One Thousand Steps stores. The co plans to engage an investment banker to assist in identifying and evaluating strategic alternatives for the demo stores, and to close the One Thousand Steps stores as soon as is practical… As a result of the actions announced today, the co estimates that it will recognize non-cash fixed asset impairment charges on demo stores of approximately $48 mln and inventory reserve charges for demo and One Thousand Steps aggregating approximately $4 mln in its third quarter ending November 3, 2007.”
16:30 NETL NetLogic to acquire Aeluros for $57 mln in cash (34.79 -0.41)

Co announces it has signed a definitive agreement to acquire Aeluros, a privately-held, fabless provider of industry-leading 10-Gigabit Interface technologies and semiconductor products. NetLogic Microsystems expects to pay $57 mln in cash upon the closing of the transaction in exchange for all of the outstanding equity securities of Aeluros. NetLogic Microsystems will reserve approximately 115,000 shares of common stock for future issuance upon the exercise of unvested employee stock options of Aeluros that will be assumed by NetLogic Microsystems and will be subject to continued employment vesting requirements. In addition, under the terms of the definitive agreement, NetLogic Microsystems may pay up to an additional $20 mln upon the attainment of performance milestones for the acquired business. The acquisition has been approved by both companies’ Board of Directors and is subject to customary closing conditions. The acquisition is expected to close within the next 10 days.
16:30 MLNX Mellanox Tech beats by $0.03; ex-itmes, slight beat on revs (22.54 -1.61)

Reports Q3 (Sep) earnings of $0.21 per share, $0.03 better than consensus estimate of $0.18; revenues rose 15% year/year to $22.7 mln vs the $21.86 mln consensus. “Our ConnectX InfiniBand adapters are enjoying wide adoption by our OEM customer base, and are being integrated into large-cluster deployments, as well as in volume-level servers, blade servers and storage devices, expanding our addressable markets. “We are also seeing initial end-user deployments of our ConnectX 10 Gigabit Ethernet adapters for use in a variety of markets,” th co said.
16:30 LFL Lan Airlines S.A. reports revs $878 mln vs $842.94 mln Reuters consensus

16:29 TYL Tyler Tech misses by $0.01, misses on revs; guides FY07 EPS in-line, revs in-line (14.15 0.00)

Reports Q3 (Sep) earnings of $0.12 per share, $0.01 worse than the Reuters Estimates consensus of $0.13; revenues rose 9.5% year/year to $54.9 mln vs the $57 mln consensus. Co issues in-line guidance for FY07, sees EPS of $0.38-0.41 vs. $0.41 consensus; sees FY07 revs of $217-220 mln vs. $219.87 mln consensus.
16:29 ATAR Atari secures $10,000,000 senior secured credit facility (2.95 +0.01)

16:29 MDCO The Medicines Co beats by $0.10, reports revs in-line (17.87 -0.13)

Reports Q3 (Sep) loss of $0.46 per share, $0.10 better than the Reuters Estimates consensus of ($0.56); revenues rose 4.4% year/year to $62.2 mln vs the $62.7 mln consensus. Angiomax U.S. sales increased to $60.7 million in the third quarter of 2007, compared to $55.7 million in the third quarter of 2006. Angiomax/Angiox international net revenues decreased to $1.5 million for the third quarter of 2007, compared to $3.4 million in the third quarter of 2006. The international net revenues in the third quarter of 2007 included $1.2 million from the new distribution agreement with Nycomed.
16:29 ICO International Coal beats by $0.03, misses on revs (5.10 -0.05)

Reports Q3 (Sep) loss of $0.01 per share, $0.03 better than the Reuters Estimates consensus of ($0.04); revenues fell 8.1% year/year to $207.8 mln vs the $222.8 mln consensus. For Y07, co expects to sell approx 18.6-19.0 mln tons of coal. The average selling price is projected to be $42.50-43.00 per ton, with average cost per ton sold expected to be $39.75-$40.25, excluding selling, general and administrative expenses. Coal production is still expected to total 17-18 mln tons for the year.
16:28 PSSI prelim $0.29, excl $0.07 in charges, vs $0.20 Reuters consensus, $0.21 First Call; revs $427.1 mln vs $446.36 mln Reuters consensus

16:28 AEIS Advanced Energy misses by $0.03, reports revs in-line; guides Q4 EPS below consensus, revs below consensus (15.83 -0.47)

Reports Q3 (Sep) earnings of $0.13 per share, $0.03 worse than the Reuters Estimates consensus of $0.16; revenues fell 16.0% year/year to $90.5 mln vs the $90.1 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.12-$0.14 vs. $0.18 consensus; sees Q4 revs of $86-$90 vs. $93.56 mln consensus. “Our rev was in line with our pre announcement due to the weakness in the semiconductor equipment market. The gross margin did not meet our objective due to the increased warranty expense. In the near term we expect to see continued softness in the semiconductor equipment and flat panel display markets with modest growth in our other markets.”
16:28 ZL Zarlink Semi reports Q2 (Sep) results; guides Q3 EPS below consensus, revs below consensus (1.40 +0.01)

Reports Q2 (Sep) loss of $0.13 per share, includes multiple chargesm, not comparable to the Reuters Estimates consensus of ($0.04); revenues rose 30.2% year/year to $49.6 mln vs the $48.1 mln consensus. Co issues downside guidance for Q3, sees loss of $0.08-0.10 vs. ($0.02) consensus; sees Q3 revs of $55-58 mln vs. $62.34 mln consensus.
16:28 STAR Starent Networks beats by $0.03, beats on revs (28.25 -1.99)

Reports Q3 (Sep) earnings of $0.08 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of $0.05; revenues rose 4.1% year/year and 19% sequentially to $36.7 mln vs the $32.7 mln consensus.
16:28 SCSS Select Comfort beats by $0.01, misses on revs; lowers FY07 guidance (12.69 -0.05)

Reports Q3 (Sep) earnings of $0.26 per share, $0.01 better than the Reuters Estimates consensus of $0.25; revenues rose 2.6% year/year to $213.1 mln vs the $215.8 mln consensus. Co issues lowered guidance for FY07, sees EPS of $0.74-0.81 vs. $0.84 consensus down from $0.87-0.93; sees FY07 revs of $820-830 mln vs. $836.39 mln consensus down from $840-860 mln.
16:27 TYL sees FY07 $0.38-0.41 vs $0.41 Reuters consensus; sees revs $217-220 mln vs $219.87 mln Reuters consensus

16:27 RCRC RC2 reports Q3 (Sep) results; guides FY07 EPS in-line, revs below consensus (28.55 -0.26)

Reports Q3 (Sep) earnings of $0.52 per share, may not be comparable to the Reuters Estimates consensus of $0.71; revenues fell 8.3% year/year to $143 mln vs the $141.1 mln consensus. Co issues mixed guidance for FY07, sees EPS of $2.05-2.18 vs. $2.08 consensus; sees FY07 revs of $465-480 mln vs. $493.11 mln consensus.
16:26 TYL prelim $0.12 vs $0.13 Reuters consensus, $0.12 First Call; revs $54.9 mln vs $56.95 mln Reuters consensus

16:26 PRXL PAREXEL beats by $0.01, beats on revs; guides Q2 EPS in-line, revs in-line; guides FY08 EPS in-line, revs above consensus (44.23 -1.32)

Reports Q1 (Sep) earnings of $0.35 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.34; revenues rose 26.0% year/year to $208.1 mln vs the $206 mln consensus. Co issues in-line guidance for Q2, sees EPS of $0.37-0.39 vs. $0.39 consensus; sees Q2 revs of $220-230 mln vs. $217.11 mln consensus. Co issues guidance for FY08, sees EPS of $1.61-1.67, excluding non-recurring items, compared to previous guidance of $1.58-1.66, vs. $1.63 consensus; sees FY08 revs of $890-920 mln, compared to previous guidance of $875-910 mln, vs. $889.48 mln consensus.
16:25 WPL W.P. Stewart suspends dividend (7.71 -0.09)

The co announces “the suspension of the regular quarterly dividend payment to common shareholders. Commenting on the decision taken today by the Board of Directors, Bill Stewart, Chairman & CEO said: “We are about eight months into a one- to two-year turnaround program, and the principal challenge is that it takes time to do it right. We’ve essentially completed the addition of strong, experienced people in most key positions; the integration of our global research and portfolio management activities and the substantial broadening of our product line. Investment performance is improving and we have reduced operating expenses.” “We continue to generate positive cash flow but we expect it will take some time before the impact of these changes takes full effect. The Board’s action today is to ensure the Company has the cash resources necessary to continue building out our global franchise, including exploring possible strategic opportunities.”
16:25 RNT Aaron Rents reports EPS in-line, revs in-line; guides Q4 EPS in-line, revs in-line; guides FY08 EPS in-line (20.98 -0.12)

Reports Q3 (Sep) earnings of $0.29 per share, in-line with the Reuters Estimates consensus of $0.29; revenues rose 13.1% year/year to $359.4 mln vs the $357.5 mln consensus. Co issues in-line guidance for Q4, sees EPS of $0.30-0.34 vs. $0.33 consensus; sees Q4 revs of $375 mln vs. $380.93 mln consensus. Co issues in-line guidance for FY08, sees EPS of $1.60-1.75 vs. $1.68 consensus.
16:25 After Hours Movers: FFIV -18%, ALGN -17%, HLYS -11%, SYMC -9.5%, NTRI -9%, AKAM -8%, FORM -7%, CRUS -6%, SCSS -3.5%

16:25 ADVS Advent Software beats by $0.05, beats on revs; reaffirms Q4 revs guidance (46.54 -2.06)

Reports Q3 (Sep) earnings of $0.12 per share, $0.05 better than the Reuters Estimates consensus of $0.07; revenues rose 21.2% year/year to $55.5 mln vs the $53.9 mln consensus. Co reaffirms guidance for Q4, sees Q4 revs of $56-$59 mln vs. $56.88 mln consensus.
16:24 PXLW sees Q4 $0.02-(0.03) vs ($0.03) Reuters consensus; sees revs $25-27 mln vs $27.75 mln Reuters consensus

16:24 MNST Monster Worldwide beats by $0.02, reports revs in-line; guides FY07 revs above consensus (36.07 -1.15)

Reports Q3 (Sep) earnings of $0.35 per share, $0.02 better than the Reuters Estimates consensus of $0.33; revenues rose 17.8% year/year to $337 mln vs the $336.4 mln consensus. Co issues upside guidance for FY07, sees FY07 revs of $1.35-$1.37 bln vs. $1.35 bln consensus. The co also announced that its Board of Directors has increased the co’s current stock repurchase authorization to $350 mln from $250 mln. Giving effect to the increased authorization and repurchases to date, the co currently has $250 mln remaining under the program.
16:24 PRXL sees FY08 $1.61-1.67 vs $1.63 Reuters consensus; sees revs $890-920 mln vs $889.48 mln Reuters consensus

16:24 VAR Varian Medical beats by $0.04, beats on revs; provides mixed DecQ guidance; guides FY08 revs slightly above consensus (43.14 +0.04)

Reports Q4 (Sep) earnings of $0.61 per share, $0.04 better than the Reuters Estimates consensus of $0.57; revenues rose 15.1% year/year to $522.4 mln vs the $509.9 mln consensus. Co issues mixed guidance for Q1 (Dec), sees EPS of $0.39-0.40 vs. $0.42 consensus; sees Q1 revs up 12-13% yr/yr which computes to $434-438 mln vs. $427.2 mln consensus. Co issues mixed guidance for FY08, sees EPS of $2.04-2.06 vs. $2.05 consensus; sees FY08 revs up 10-11% which equates to $1.96-1.97 bln vs. $1.94 bln consensus.
16:23 CVA Covanta misses by $0.02, beats on revs; reaffirms FY07 EPS guidance (24.42 +0.36)

Reports Q3 (Sep) earnings of $0.24 per share, excluding non-recurring items, $0.02 worse than the Reuters Estimates consensus of $0.26; revenues rose 13.3% year/year to $352.4 mln vs the $338.3 mln consensus. Co reaffirms guidance for FY07, sees EPS of $0.65-0.75 vs. $0.74 consensus.
16:23 PXLW prelim ($0.02) vs ($0.03) Reuters consensus; revs $28.1 mln vs $27.73 mln Reuters consensus

16:23 WSTL Westell Tech reports EPS in-line, beats on revs; guides Q3 EPS below consensus, revs below consensus

Reports Q2 (Sep) loss of $0.01 per share, in-line with the Reuters Estimates consensus of ($0.01); revenues rose 2.5% year/year to $60.4 mln vs the $59.1 mln consensus. Co issues downside guidance for Q3, sees EPS of (0.06)-(0.07) vs. $0.01 consensus; sees Q3 revs of $43-45 mln vs. $61.05 mln consensus.
16:23 SMDI Sirenza Micro beats by $0.01, misses on revs (16.61 -1.66)

Reports Q3 (Sep) earnings of $0.18 per share, $0.01 better than the Reuters Estimates consensus of $0.17; revenues rose 15.6% year/year to $45.9 mln vs the $48.2 mln consensus.
16:23 FFIV F5 Networks reports Q4 (Sep) results, beats on revs; guides Q1 EPS below consensus, revs in-line (40.47 -3.80)

Reports Q4 (Sep) earnings of $0.15 per share, including a charge, may not be comparable to the Reuters Estimates consensus of $0.10. Co issues mixed guidance for Q1, sees EPS of $0.20-0.21 vs. $0.24 consensus; sees Q1 revs of $154-156 mln vs. $155.64 mln consensus. “Excluding Acopia, our single biggest investment during the year, we added approximately 385 employees across the organization, the majority in sales and marketing, product development and service. We continue to believe that our investments in sales and marketing will have a significant impact on our revenue growth in the coming year and enable us to further expand our share of the growing application delivery networking market. Meanwhile, we are seeing returns on our investment in R&D in the delivery of market-expanding products like WANJet on TMOS, announced today, and in our progress toward the delivery of our next generation chassis platform code named Montreal by calendar year end. Equally important, our investments in our service business have enabled us to provide a growing array of services and to respond more quickly to customers’ needs. As a result, we believe F5 is well-positioned to extend its leadership in application delivery networking and to become a leader in the emerging file virtualization market through our newly acquired data solutions business.”
16:23 PRXL sees Q2 $0.37-0.39 vs $0.39 Reuters consensus; sees revs $220-230 mln vs $217.11 mln Reuters consensus

16:23 ACF AmeriCredit misses by $0.12, beats on revs; guides FY08 EPS below consensus (16.00 -1.0

Reports Q1 (Sep) earnings of $0.49 per share, $0.12 worse than the Reuters Estimates consensus of $0.61; revenues rose 24.7% year/year to $652.7 mln vs the $645 mln consensus. Co issues downside guidance for FY08, sees EPS of $2.30-$2.50 (lowered from previous range of $2.50-$2.75) vs. $2.56 consensus. “While we saw normal seasonal credit deterioration during the September quarter, we also experienced weaker than expected results primarily from loans originated in 2006. As a result of this underperformance and a potentially softer economy in the near term, we have boosted the provision for loan losses for the quarter, which reduced our net income.”
16:23 AMGN Amgen beats by $0.05, reports revs in-line; reaffirms FY07 EPS guidance

Reports Q3 (Sep) earnings of $1.08 per share, excluding non-recurring items, $0.05 better than the Reuters Estimates consensus of $1.03; revenues were unchanged from the year-ago period at $3.61 bln. Co reaffirms guidance for FY07, sees EPS of $4.13-4.23 vs. $4.19 consensus. For individual drug sales number vs consensus expectation, see 16:12 comment.
16:22 FISV Fiserv beats by $0.01, misses on revs; guides FY07 EPS to lower end of prior range (52.16 -0.30)

Reports Q3 (Sep) earnings of $0.72 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.71; revenues rose 4.5% year/year to $1.17 bln vs the $1.2 bln consensus. Co guides for FY07, sees EPS at the low end of $2.74-2.82 vs. $2.76 consensus.
16:22 PRXL prelim $0.35 vs $0.34 Reuters consensus; revs $208.1 mln vs $206.00 mln Reuters consensus

16:22 GDI sees Q4 $0.87-0.92 vs $0.79 Reuters consensus

16:22 WOOF VCA Antech beats by $0.01, beats on revs; guides FY07 EPS in-line, revs in-line (44.22 -0.2

Reports Q3 (Sep) earnings of $0.38 per share, $0.01 better than the Reuters Estimates consensus of $0.37; revenues rose 21.8% year/year to $306.5 mln vs the $300.9 mln consensus. Co issues in-line guidance for FY07, sees EPS of $1.39-1.40 vs. $1.40 consensus; sees FY07 revs of $1.15-$1.16 bln vs. $1.15 bln consensus.
16:21 CLDN Celadon Group reports Q1 (Sep) results, revs in-line (9.67 +0.06)

Reports Q1 (Sep) earnings of $0.11 per share, may include gains or charges, may not be comparable to the Reuters Estimates consensus of $0.21; revenues rose 4.8% year/year to $133.8 mln vs the $132.9 mln consensus.
16:21 MSFT Microsoft confirms Facebook Strategic Alliance (31.25 +0.35) -Update-

The co announces “that Microsoft will take a $240 mln equity stake in Facebook’s next round of financing at a $15 bln valuation, and the cos will expand their existing advertising partnership. Under the expanded strategic alliance, Microsoft will be the exclusive third-party advertising platform partner for Facebook, and will begin to sell advertising for Facebook internationally in addition to the United States.”
16:21 TSCO Tractor Supply misses by $0.04, reports revs in-line; lowers FY07 guidance (43.98 -0.86)

Reports Q3 (Sep) earnings of $0.44 per share, $0.04 worse than the Reuters Estimates consensus of $0.48; revenues rose 12.5% year/year to $629.2 mln vs the $631.8 mln consensus. Co lowers guidance for FY07, lowers their EPS guidance to $2.37-2.43 vs. $2.50 consensus down from previous $2.49-2.56; and lowers their FY07 revs to $2.68-2.70 bln vs. $2.71 bln consensus down from $2.7-2.75 bln.
16:21 SYMC Symantec beats by $0.03, beats on revs; guides Q3 EPS below consensus, revs below consensus (21.02 +0.06)

Reports Q2 (Sep) earnings of $0.29 per share, excluding non-recurring items, $0.03 better than the Reuters Estimates consensus of $0.26; revenues rose 12.9% year/year to $1.44 bln vs the $1.39 bln consensus. Co issues downside guidance for Q3, sees EPS of 0.25-0.30 vs. $0.31 consensus; sees Q3 revs of $1425-1465 bln vs. $1.47 bln consensus.
16:20 FFIV F5 Networks announces that Tom Hull is resigning as the company’s Senior Vice President of Worldwide Sales (40.47 -3.80) -Update-

16:20 GDI prelim $0.80, excl $0.19 tax benefit, vs $0.75 Reuters consensus; revs $457.2 mln vs $450.40 mln Reuters consensus

16:20 STTS STATS ChipPAC beats by $0.03, beats on revs (11.36 +0.16)

Reports Q3 (Sep) earnings of $0.13 per share, $0.03 better than the Reuters Estimates consensus of $0.10; revenues rose 4.3% year/year to $414.2 mln vs the $402.3 mln consensus. Co does not intend to host a conference call to discuss its results for Q3 or its future quarterly results. In addition, co will no longer provide revenue or earnings guidance to analysts and investors on its future quarterly results.
16:20 PALM Palm names Jon Rubinstein Exec Chairman and other board of directors (19.18 +0.16)

The co announces that “Jon Rubinstein, former senior vice president of hardware engineering and head of the iPod division at Apple, has joined Palm as executive chairman of the board, and Fred Anderson and Roger McNamee, managing directors and co-founders of Elevation, have joined Palm’s board of directors. Rubinstein, Anderson, and McNamee replace Eric Benhamou and Bruce Dunlevie, who resigned from Palm’s board of directors. The total number of directors on the board has been increased from eight to nine in connection with the transaction.”
16:19 MTSN Board of Directors has authorized an additional $30 million share repurchase

16:19 ALGN Align Tech beats by $0.04, reports revs in-line; guides Q4 GAAP EPS below consensus, revs below consensus

Reports Q3 (Sep) GAAP earnings of $0.13 per share, $0.04 better than the Reuters Estimates consensus of $0.09; revenues rose 45.8% year/year to $71.5 mln vs the $71.4 mln consensus. Co issues downside guidance for Q4, sees GAAP EPS of $0.06-0.09 vs. $0.11 consensus (it’s unclear whether consensus is GAAP or non-GAAP); sees Q4 revs of $69.5-72.2 mln vs. $73.96 mln consensus. “I’m pleased with the financial results for the third quarter with rev growth of 46% YoY and EPS four cents higher than expectations. Continued improvement from operations and stable ASPs resulted in stronger than expected gross margin of 74.6%…”
16:18 ABAX Abaxis misses by $0.01, beats on revs (24.19 -0.4

Reports Q2 (Sep) earnings of $0.13 per share, $0.01 worse than the Reuters Estimates consensus of $0.14; revenues rose 19.8% year/year to $25.2 mln vs the $23.7 mln consensus.
16:18 MTSN sees Q4 ($0.06) - $0.05 vs $0.05 Reuters consensus; sees revs $45-55 mln vs $58.86 mln Reuters consensus

16:18 CSGP CoStar Group beats by $0.03, reports revs in-line; guides Q4 EPS in-line (61.28 +1.72)

Reports Q3 (Sep) earnings of $0.17 per share, $0.03 better than the Reuters Estimates consensus of $0.14; revenues rose 3.1% year/year to $49.3 mln vs the $49.7 mln consensus. Co issues in-line guidance for Q4, sees EPS of 0.19-0.21 vs. $0.21 consensus.
16:18 MTSN prelim $0.04, excl $0.03 tax benefit, vs $0.06 Reuters consensus, $0.05 First Call; revs $58.5 mln vs $61.09 mln Reuters consensus

16:17 FFIV sees Q1 $0.20-0.21 vs $0.24 Reuters consensus; sees revs $154-156 mln vs $155.64 mln Reuters consensus

16:17 AEA prelim $0.16, ex items, vs $0.22 Reuters consensus; revs $183.9 mln vs $189.55 mln Reuters consensus

16:17 HPC remain confident in growth strategy and optimistic about both earnings and cash flow growth for the balance of the year and as they look to 2008

16:17 FFIV prelim $0.15, may not be comparable to $0.10 Reuters consensus, $0.11 First Call; revs $145.6 mln vs $144.07 mln Reuters consensus

16:17 ZL sees Q3 ($0.08-0.10) ex items vs ($0.02) Reuters consensus; sees revs $55-58 mln vs $62.34 mln Reuters consensus

16:16 EXBD sees Q4 $0.59-0.64, excl $0.02 item, vs $0.62 Reuters consensus

16:16 CPWR prelim $0.17 vs $0.09 Reuters consensus, $0.10 First Call; revs $302.0 mln vs $284.70 mln Reuters consensus

16:16 ZL prelim ($0.13) includes charges not comparable to ($0.04) Reuters consensus; revs $49.6 mln vs $48.14 mln Reuters consensus

16:16 GILD Gilead Sciences’ Board Member Paul Berg establishes rule 10b5-1 stock trading plan (43.96 +0.94)

16:16 EXTR prelim $0.04 vs $0.02 Reuters consensus; revs $89.0 mln vs $87.9 mln Reuters consensus

16:16 ADVS sees Q4 revs $56-59 mln vs $56.88 mln Reuters consensus

16:16 HPC prelim $0.37 vs $0.41 Reuters consensus; revs $544.2 mln vs $550.93 mln Reuters consensus

16:15 EXBD prelim $0.59 vs $0.52 Reuters consensus; revs $136.3 mln vs $137.60 mln Reuters consensus

16:15 ADVS prelim $0.12 vs $0.07 Reuters consensus; revs $55.5 mln vs $53.86 mln Reuters consensus

16:15 AFFX Affymetrix files second wave of patent infringement lawsuits against Illumina in US and Europe (27.12 -0.19)

Co announces that it has filed additional patent infringement lawsuits against Illumina Inc. in the United States District Court for the District of Delaware, in the U.K. High Court of Justice, Chancery Division, Patents Court and in the German Dusseldorf Regional Court, Patent Division. Affymetrix is seeking all available remedies, including injunctive relief. The new suits target technology offered by Solexa(R), the company acquired by Illumina in January 2007, as well as all of Illumina’s BeadArray(TM) products. Affymetrix also filed new lawsuits in Germany and the U.K. because the infringing acts extend beyond the U.S. market.
16:15 AXYS Axsys Technologies re[prts Q3 EPS of $0.34 ex items vs $0.29 Reuters consensus; revs rose 34% to $45.2 mln vs $42.02 mln Reuters consensus (31.81 +0.86)

Co raises FY07 guidance sees EPS of $1.24-1.26 vs $1.18 Reuters consensus up from $1.13-1.16 ; sees revs $168-171 mln vs $168.94 mln Reuters consensus up from $159-163 mln. Co also sees FY08 $1.57-1.60 vs $1.48 Reuters consensus; sees revs $193-197 mln vs $187.76 mln Reuters consensus
16:14 RNOW Rightnow Tech beats by $0.04, beats on revs; guides Q4 EPS above consensus, revs above consensus; guides FY07 EPS above consensus, revs in-line (16.85 -0.13)

Reports Q3 (Sep) loss of $0.07 per share, excluding non-recurring items, $0.04 better than the Reuters Estimates consensus of ($0.12); revenues fell 3.0% year/year to $29.2 mln vs the $27.7 mln consensus. Co issues upside guidance for Q4, sees EPS of -0.06-0.07 vs. ($0.10) consensus; sees Q4 revs of $29.5 mln vs. $29.07 mln consensus. Co issues mixed guidance for FY07, sees EPS of -0.39-0.40 vs. ($0.47) consensus; sees FY07 revs of $111 mln vs. $108.91 mln consensus.
16:14 STAR prelim $0.08 vs $0.05 Reuters consensus; revs $36.7 mln vs $32.65 mln Reuters consensus

16:14 SKX Skechers USA beats by $0.09, beats on revs; guides Q4 EPS below consensus, revs below consensus (21.94 +0.40)

Reports Q3 (Sep) earnings of $0.53 per share, $0.09 better than the Reuters Estimates consensus of $0.44; revenues rose 19.3% year/year to $395 mln vs the $382.4 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.26 - $0.31 vs. $0.33 consensus; sees Q4 revs of $305 - $315 vs. $339.97 mln consensus.
16:14 CYBE CyberOptics reports Q3 EPS of $0.15, excludes items, vs $0.15 Reuters consensus; revs rose 16% YoY to $16.17 mln vs ($15.35 mln two analyst est) (13.64 +0.89)

16:14 CRUS Cirrus Logic reports Q2 (Sep) results, misses on revs; guides Q3 revs in-line (6.98 -0.43)

Reports Q2 (Sep) net of breakeven, includes multiple gains, charges, may not be comparable to the Reuters Estimates consensus of $0.08; revenues rose 14.4% year/year to $47 mln vs the $48.6 mln consensus. Co issues in-line guidance for Q3, sees Q3 revs of $47-51 mln vs. $50.67 mln consensus.
16:13 RYL has amended its revolving credit facility by reducing its borrowing capacity to $750.0 million from $1.1 billion

16:12 ARG Airgas beats by $0.04, beats on revs; guides Q3 EPS in-line; guides FY08 EPS above consensus (51.04 -1.02)

Reports Q2 (Sep) earnings of $0.67 per share, excluding non-recurring items, $0.04 better than the Reuters Estimates consensus of $0.63; revenues rose 27.4% year/year to $1.01 bln vs the $0.99 bln consensus. Co issues in-line guidance for Q3, sees EPS of $0.64-0.66, excluding non-recurring items, vs. $0.65 consensus. Co issues upside guidance for FY08, sees EPS of $2.62-2.67, compared to previous guidance of $2.49-2.57, excluding non-recurring items, vs. $2.60 consensus.
16:12 MSFT Microsoft to invest $250 mln for minority stake in Facebook - WSJ (31.25 +0.35)

Microsoft beats Google (GOOG) to sell intl ads on Facebook - WSJ
16:12 AMGN Amgen Drug Sales (58.13 +0.43) -Update-

Drug Actual (mln) Street Expectation (mln)
Aranesp WW $818 $807
Neulasta WW $763 $765
Neupogen WW $337 $301
Enbrel WW $821 $828
Sensipar $122 $111
Vectibix $41 $51
16:11 RYL prelim $0.46, excl items, may not be comparable to ($0.57) Reuters consensus; revs $732.3 mln vs $790.40 mln Reuters consensus

16:11 MNST sees FY07 sees revs $1.35-1.37 mln vs $1.35 bln Reuters consensus

16:11 ACF sees FY08 $2.30-2.50 vs $2.56 Reuters consensus

16:11 IDTI Integrated Device: Greg Lang will resign as CEO and President upon completion of a search for a successor (13.36 -0.50)

16:11 AMGN reaffirms FY07 $4.13-4.23 vs $4.19 Reuters consensus

16:11 NTRI Nutrisystem beats by $0.02, reports revs in-line; guides Q4 revs below consensus; guides FY07 revs below consensus (27.50 +0.01)

Reports Q3 (Sep) earnings of $0.64 per share, $0.02 better than the Reuters Estimates consensus of $0.62; revenues rose 21.3% year/year to $188.3 mln vs the $188.1 mln consensus. Co issues downside guidance for Q4, sees Q4 revs of $133.6 mln vs. $144.37 mln consensus. Co issues downside guidance for FY07, sees FY07 revs of $770-776 mln vs. $784.42 mln consensus. Due to the recently announced investment in ZeroWater, co will now provide guidance for operating income going forward, rather than earnings per share. For Q4 co estimates operating income to be between $16-19 mln. This guidance includes approximately $3.5 million of non-cash compensation, depreciation and amortization. This guidance does not include approximately $2 million of NutriSystem’s estimated proportionate share in ZeroWater’s loss. ForY07 expects operating income to be between $163-166 mln. This guidance includes about $10.5 million of non-cash compensation, depreciation and amortization. This guidance does not include approximately $2 million of NutriSystem’s estimated proportionate share in ZeroWater’s loss.
16:11 MNST prelim $0.35 vs $0.33 Reuters consensus; revs $337.0 mln vs $336.36 mln Reuters consensus

16:10 AFFX Affymetrix beats by $0.08, beats on revs; guides FY07 revs in-line (27.12 -0.19)

Reports Q3 (Sep) earnings of $0.14 per share, $0.08 better than the Reuters Estimates consensus of $0.06; revenues rose 12.2% year/year to $95 mln vs the $93 mln consensus. Co issues in-line guidance for FY07, sees FY07 revs of $365 - $375 vs. $373.05 mln consensus.
16:10 ACF prelim $0.49 vs $0.61 Reuters consensus; revs $652.7 mln vs $644.95 mln Reuters consensus

16:10 AMGN prelim $1.08 vs $1.03 Reuters consensus; revs $3.61 bln vs $3.58 bln Reuters consensus

16:10 SGMO Sangamo BioSci beats by $0.03, misses on revs

Reports Q3 (Sep) loss of $0.11 per share, $0.03 better than the Reuters Estimates consensus of ($0.14); revenues rose 27.8% year/year to $2.3 mln vs the $2.7 mln consensus. Q3 revs were primarily from SGMO’s agreements with Dow AgroSciences (DOW), Sigma-Aldrich (SIAL), private foundation research grants, and enabling technology agreements in protein production.
16:10 LNCR Lincare announces it will commence a $500 mln convertible notes offering; $250 mln of which are series A and $250 mln are series B; co also announces a $150 mln share repurchase program concurrent with the offering (34.99 -0.01)

16:09 NUVA sees FY07 ($0.31-0.35) vs ($0.35) Reuters consensus; sees revs $147-148 mln vs $145.59 mln Reuters consensus

16:09 AGP sees Y07 organic premium rev growth of approx 37%, compared to previous guidance of 35%

16:09 QTM prelim $0.04 vs $0.02 Reuters consensus; revs $249 mln vs $260.33 mln Reuters consensus

16:08 QDEL prelim $0.07 vs $0.06 Reuters consensus; revs $27.6 mln vs $27.53 mln Reuters consensus

16:08 STR sees FY08 $2.85-3.00 vs $3.03 Reuters consensus

16:08 AGP sees FY08 $2.45-2.60 vs $2.35 Reuters consensus; sees organic premium rev growth above 15%

16:08 RELL Richardson Electronics elects Dvorak as CFO (7.33 -0.33)

16:08 AKAM Akamai Tech beats by $0.01, reports revs in-line (32.97 -1.43)

Reports Q3 (Sep) earnings of $0.34 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.33; revenues rose 44.6% year/year to $161.2 mln vs the $161 mln consensus. The number of customers under long-term services contracts at the end of the third quarter increased by 61 to a record 2,616, a 22% increase year-over-year. Sales through resellers and sales outside the United States accounted for 18 percent and 23 percent, respectively, of revenue for the third quarter 2007. “We were very pleased with our third quarter results and the demand we saw for our services, especially as we experienced increased momentum during September… We saw strong growth across all of our core markets, as we continued to support our broad customer base with innovative solutions to help them realize the potential of their online businesses.”
16:08 NUVA prelim ($0.07) vs ($0.09) Reuters consensus; revs $38.5 mln vs $36.27 mln Reuters consensus

16:08 STR sees FY07 $2.75-2.80, up from $2.60-2.68, vs $2.73 Reuters consensus

16:08 AGP sees FY07 $2.12-2.14 vs $2.07 Reuters consensus

16:08 SYMC sees Q3 $0.25-0.30 vs $0.31 Reuters consensus; sees revs $1425-1465 mln vs $1.47 bln Reuters consensus

16:08 AGP prelim $0.58 vs $0.52 Reuters consensus; revs $1.03 bln vs $1.02 bln Reuters consensus

16:07 ALGN sees Q4 $0.06-0.09 vs $0.11 Reuters consensus; sees revs $69.5-72.2 mln vs $74.0 mln Reuters consensus

16:07 FNF prelim $0.28 ex charge vs $0.29 Reuters consensus; revs $1.36 bln vs $1.42 bln Reuters consensus

16:07 NTRI Nutrisystem makes strategic investment in Zero Water (27.50 +0.01) -Update-

The co announces “that it has acquired a preferred minority equity interest in Zero Technologies, a leading manufacturer of patented water filters and consumer water products. Zero Water has a reputation as an industry leader in consumer water purification. In addition to the equity investment, NutriSystem and ZeroWater have entered into a strategic co-marketing agreement which includes NutriSystem marketing and selling ZeroWater filters and products to NutriSystem’s customers and prospects.”
16:07 CDNS sees Q4 $0.45- $0.47 vs $0.46 Reuters consensus; sees revs $465-475 mln vs $468.66 mln Reuters consensus

16:07 CVD sees FY07 EPS of $2.65 vs $2.64 Reuters consensus; for 2008 co is targeting rev growth in the low-to- mid range and EPS growth of 20%

16:07 STR prelim $0.64 vs $0.54 Reuters consensus, $0.53 First Call; revs $497.4 mln vs $584.45 mln Reuters consensus

16:07 VMW VMware beats by $0.06, beats on revs

Reports Q3 (Sep) earnings of $0.23 per share, excluding non-recurring items, $0.06 better than the Reuters Estimates consensus of $0.17; revenues rose 89.5% year/year to $357.8 mln vs the $333.5 mln consensus.
16:07 ICO prelim ($0.01) vs ($0.04) Reuters consensus; revs $207.8 mln vs $222.78 mln Reuters consensus

16:07 CDNS prelim $0.33 vs $0.32 Reuters consensus; revs $401 mln vs $401.31 mln Reuters consensus

16:07 SYMC prelim $0.29 vs $0.26 Reuters consensus; revs $1.44 bln vs $1.39 bln Reuters consensus

16:06 SMMX sees Q4 ($0.29-0.37), does not comapre to the $0.08 Reuters consensus; sees revs $40-46 mln vs $34.35 mln Reuters consensus

16:06 MRCY sees Q2 $0.05 vs ($0.03) Reuters consensus; sees revs $51 mln vs $53.37 mln Reuters consensus

16:06 TQNT sees Q4 $0.08-0.10 vs $0.09 Reuters consensus; sees revs $125-130 mln vs $126.08 mln Reuters consensus

16:06 MRCY raises FY08 EPS guidance to $0.33 from $017 vs $0.10 Reuters consensus; reaffirms revs $225 mln vs $222.42 mln Reuters consensus

16:06 ALGN prelim $0.13 vs $0.09 Reuters consensus; revs $71.5 mln vs $71.38 mln Reuters consensus

16:06 CVD prelim $0.69 vs $0.68 Reuters consensus; revs $396 mln vs $391.97 mln Reuters consensus

16:06 NTRI sees Q4 revs flat YoY, which is ~$155.3 mln vs $144.37 mln Reuters consensus

16:06 MCRI prelim $0.41 vs $0.38 Reuters consensus; revs $43.6 mln vs $41.77 mln Reuters consensus

16:05 SMMX prelim $0.73, includes gains, does not compare to ($0.03) Reuters consensus; revs $26.1 mln vs $26.18 mln Reuters consensus

16:05 TQNT prelim $0.08 ex items vs $0.06 Reuters consensus; revs $123 mln vs $116.49 mln Reuters consensus

16:05 AB AllianceBernstein reports Q3 EPS of $1.20 vs $1.13 consensus; revs $1.15 bln vs $1.15 bln consensus (88.22 -0.55)

16:05 NTRI Nutrisystem Names David D. Clark as CFO (27.50 +0.01) -Update-

16:05 SMDI prelim $0.18 vs $0.17 Reuters consensus; revs $45.9 mln vs $48.15 mln Reuters consensus

16:05 NTRI sees Q4 revs flat YoY

16:05 STTS will no longer provide rev or earnings guidance

16:05 MRCY prelim $0.09 vs ($0.09) Reuters consensus; revs $49.2 mln vs $47.50 mln Reuters consensus

16:04 STTS prelim $0.13 vs $0.10 Reuters consensus; revs $414.2 mln vs $402.30 mln Reuters consensus

16:04 ESRX sees FY07 $2.28-2.32 vs $2.28 Reuters consensus

16:04 ALGN Align Tech CFO Eldon Bullington to Retire; VP of Finance Kenneth B. Arola to be Appointed CFO (28.70 +0.22)

16:04 NTRI prelim $0.64 vs $0.62 Reuters consensus, $0.63 First Call; revs $188.3 mln vs $188.14 mln Reuters consensus

16:04 RNOW sees Q4 ($0.10-0.11) vs ($0.10) Reuters consensus; sees revs $29.5 mln vs $29.07 mln Reuters consensus

16:04 EXEL Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference (11.24 -0.14) -Update-

…
16:04 ESRX prelim $0.60 vs $0.57 Reuters consensus; revs $4.52 bln vs $4.58 bln Reuters consensus

16:03 HLYS Heelys lowers guidance (8.43 -0.39) -Update-

Sees Q3 EPS of $0.22-0.23 vs $0.29 Reuters consensus; revs $49 mln vs $56.20 mln Reuters consensus. “Throughout the third quarter we took a number of steps to reduce the amount of inventory in our current domestic distribution channels, including increasing our national advertising and providing additional markdown assistance. While we appear to have made some important progress, the difficult retail environment over the past several months resulted in higher than anticipated order cancellations, increased promotional activity and rescheduled shipments, all of which negatively impacted our net sales and earnings. We continue to believe in the long-term prospects of our brand and products; however over the near-term, we expect that our business will remain challenging.”
16:03 KAI prelim $0.40 vs $0.37 Reuters consensus; revs $92.7 mln vs $92.25 mln two analyst est

16:03 CLDN prelim $0.11 vs $0.21 Reuters consensus; revs $133.8 mln vs $132.87 mln Reuters consensus

16:03 BBSI prelim $0.54 vs $0.57 Reuters consensus; revs $296.76 mln vs $297.63 mln Reuters consensus

16:03 TSCO lowers FY07 EPS to $2.37-2.43 vs $2.50 Reuters consensus; lowers revs to $2.68-2.70 bln vs $2.71 bln Reuters consensus

16:03 FADV prelim $0.34, excluding $0.02 in pre-tax restructuring charges, vs $0.31 Reuters consensus; revs $219.41 mln vs $225.05 mln Reuters consensus

16:03 VAR sees FY08 $2.04-2.06 vs $2.05 Reuters consensus

16:02 LOOP sees FY07 $0.49-0.50 vs $0.47 Reuters consensus; sees revs $70.1-70.3 mln vs $69.23 mln Reuters consensus

16:02 CSGP sees Q4 $0.19-0.21 vs $0.21 Reuters consensus

16:02 MDCO prelim ($0.46), ex items, vs ($0.56) Reuters consensus, ($0.57) First Call; revs $62.2 mln vs $62.71 mln Reuters consensus

16:02 EXEL Exelixis: Interim phase 2 data for Exelixis’ XL880 show anti-tumor activity in Papillary Renal Cell (11.24 -0.14)

The co announces “encouraging data from an ongoing phase 2 trial of XL880, an inhibitor of MET and VEGFR2 kinases, in patients with papillary renal cell carcinoma. Of 19 patients with measurable disease evaluable for tumor responses, 15 (79%) have had a decrease in tumor size (4-33%), including one patient with a partial response. All 19 evaluable patients with at least one post-baseline tumor assessment have had stable disease for at least three months, including 12 patients with stable disease for six months to 15+ months. Results of preliminary analyses of plasma biomarkers and tumor samples are consistent with inhibition of angiogenesis and proliferation and an increase in apoptosis… As of October 10, 2007, a total of 21 patients have been enrolled in this ongoing study: Five with activating MET mutations and 16 with wild type MET. Sixteen patients were evaluable for safety endpoints.”
16:02 AKAM prelim $0.34 vs $0.33 Reuters consensus; revs $161.2 mln vs $161.03 mln Reuters consensus

16:02 MGRM Monogram Biosciences reports Q3 EPS of ($0.02) vs ($0.06) Reuters consensus; revs $10.4 mln vs $10.00 mln Reuters consensus (1.47 -0.05)

16:02 CSGP prelim $0.17 may not be comparable to $0.14 Reuters consensus; revs $49.3 mln vs $49.68 mln Reuters consensus

16:02 VAR sees Q1 $0.39-0.40 vs $0.42 Reuters consensus

16:02 LOOP sees Q4 $0.11-0.12 vs $0.12 Reuters consensus; sees revs $18.9-19.1 mln vs $18.78 mln Reuters consensus

16:02 RNOW prelim ($0.11) vs ($0.12) Reuters consensus, ($0.11) First Call; revs $29.2 mln vs $27.66 mln Reuters consensus

16:02 TSCO prelim $0.44 vs $0.48 Reuters consensus, $0.47 First Call; revs $629.2 mln vs $631.79 mln Reuters consensus

16:02 HLYS sees Q3 revs $49.00 mln vs $56.20 mln Reuters consensus

16:02 FORM doesn’t report EPS due to to inventory valuations review; revs $125.3 mln vs $125.57 mln Reuters consensus

16:01 AFFX sees FY07 revs $365-375 mln vs $373.05 mln Reuters consensus

16:01 HLYS Heelys lowers guidance; sees Q3 EPS of $0.22-0.23 vs $0.29 Reuters consensus -Update-

16:01 VMW prelim $0.23 vs $0.17 Reuters consensus; revs $358 mln vs $333.48 mln Reuters consensus

16:01 LOOP prelim $0.14 vs $0.12 Reuters consensus; revs $18.6 mln vs $17.92 mln Reuters consensus

16:01 SRX SRA Intl: Small Business Administration awards $30 mln contract to SRA (28.26 -0.14)

The co announces that it “has been awarded a task order to provide a managed hosting solution for major information systems at the Small Business Administration. The task order, awarded in September under the Chief Information Officer Solutions and Partners 2 Innovations contract, has an estimated value of $30 mln over four years if all options are exercised.”
16:01 WOOF prelim $0.38 vs $0.37 Reuters consensus; revs $306.5 mln vs $300.92 mln Reuters consensus

16:01 CRUS sees Q3 revs $47-51 mln vs $50.67 mln Reuters consensus

16:01 SKX sees Q4 $0.26-0.31 vs $0.33 Reuters consensus; sees revs $305-315 mln vs $339.97 mln Reuters consensus

16:01 AFFX prelim $0.14, ex-items, may not be comparable to $0.06 Reuters consensus; revs $95 mln vs $92.98 mln Reuters consensus

16:01 VAR prelim $0.61 vs $0.57 Reuters consensus; revs $522.4 mln vs $509.89 mln Reuters consensus

16:01 CRUS prelim $0.00 may not be comparable $0.08 Reuters consensus; revs $47.0 mln vs $48.62 mln Reuters consensus

16:01 ABAX prelim $0.13 vs $0.14 Reuters consensus; revs $25.2 mln vs $23.65 mln Reuters consensus

16:01 CBZ CBIZ acquires $30 mln co Healthcare Business Resources (8.59 -0.21)

The co announces “that it has entered into a definitive agreement to acquire Healthcare Business Resources, a prominent emergency medicine billing co…This transaction is not expected to have a significant impact on financial results for CBIZ in 2007. It is expected to contribute approximately $6.0 mln to EBITDA in 2008 and, after considering the expected financing and amortization expenses in connection with this transaction, the results from this acquisition are expected to contribute $0.01 to $0.02 to earnings per share in 2008.”
16:00 AEIS prelim $0.13 vs $0.16 Reuters consensus; revs $90.5 mln vs $90.10 mln Reuters consensus

16:00 SGMO prelim ($0.11) vs ($0.14) Reuters consensus; revs $2.3 mln vs $2.68 mln Reuters consensus

16:00 SKX prelim $0.53 vs $0.44 Reuters consensus; revs $395 mln vs $382.37 mln Reuters consensus

16:00 SCSS prelim $0.26 vs $0.25 Reuters consensus; revs $213.1 mln vs $215.84 mln Reuters consensus

Core Self-Evaluations and Trading Success

Mortgage Resets? Try Chapter 13 Bankruptcy!

Flashing Lights

List of Chinese ADR’s

CTX monster housing Losses

Chinese P/E ratios

One Man

Yes, some blogs are profitable - very profitable

Fibonacci Retracements and Trading Ranges

Baby Loves Disco? I love the web.

Cheaters, Thieves, and Angle Shooters

Spirit Live

Foreclosures/1000 Homes by City

Millennium Cell — Running on Empty Fuel Cells

GoodTimes Good Times

I want them alive… No modifications!

Prime Loans gone Bad

The Shins still a great band

Market trying off the open to rally once again, but lower lows the mantra and I continue to believe you have to sell the rips and buy the dips until the FED next week. So we are going nowhere but trading happens and money can be made in this market. So keep on selling those lower rips and buy the higher dips.

08:17 UA Under Armour: Weather capping near-term upside but checks point to ongoing brand strength, long-term thesis intact_ Thomas Weisel (57.18 )

Thomas Weisel says unseasonably warm weather from late Sept through the late weeks of October has kept many fall sports athletes from transitioning to cold weather apparel. The firm says FY guidance is achievable but upside potential seems less likely. Firm says given the inventory position at retail exiting the fall sports season, they expect 4Q reorders of Under Armour seasonal core styles such as ColdGear will suffer accordingly and are trimming 4Q estimates. Softness in reorders may limit upside. Firm cuts their 4Q rev and EPS ests to $168.5 mln and $0.32 from $182.4 mln and $0.38. (consensus is $180.39 mln and $0.34)
08:17 NOC Northrop Grumman beats by $0.08 ex gain; guides FY07 EPS above consensus, revs in-line (79.53 )

Reports Q3 (Sep) earnings of $1.35 per share, excluding $0.06 gain, $0.08 better than the Reuters Estimates consensus of $1.27; revenues rose 6.7% year/year to $7.93 bln vs the $7.95 bln consensus. Co issues mixed guidance for FY07, sees EPS of $5.10 vs. $5.05 consensus; reaffirms FY07 revs of $31.5 bln vs. $31.61 bln consensus.
08:16 INSID Insider trading disclosed in filings after the close yesterday

Buyers: National Coal (NCOC 3.16) 10% Owner J-K Navigator Fund bought 2,549,324 shares at $3.00… Comsys IT Partners (CITP 17.53) 10% Owner Amalgamated Gadget LP bought 30,700 shares at $16.37… Main Street Capital (MAIN 14.69) CEO bought 6,600 shares at $14.69… Knology (KNOL 16.70) 10% Owner Farallon Capital Partners bought 28K shares at $15.78… STAAR Surgical (STAA 3.02) 10% Owner Broadwood Partners bought 40K shares at $2.95… Platinum Energy Resources (PRGI.OB 7.76) CEO bought 1,883,913 shares at $7.77… Sellers: Northern Trust (NTRS 72.29) Director sold 69,998 shares at $69.38- $69.70… Arena Pharma (ARNA 10.05) 10% Owner Deerfield International sold 25K shares at $10.51… Mac-Gray (TUC 13.76) 10% Owner S. MacDonald sold 87,400 shares at $13.90… Seagate (STX 27.77) Officer sold 16,400 shares at $27.27… Landec (LNDC 15.00) Director sold 52,604 shares at $14.79… Renasant (RNST 23.07) Officer sold 40K shares at $22.70… Marvell Technology (MRVL 18.03) Dircector sold 27,200 shares at $17.88 - $18.04.
08:15 AN AutoNation beats by $0.01, misses on revs (17.37 )

Reports Q3 (Sep) earnings of $0.39 per share, $0.01 better than the Reuters Estimates consensus of $0.38; revenues fell 5.2% year/year to $4.6 bln vs the $4.69 bln consensus. Co authorizes an additional share repurchase of $250 mln. Co has $11.6 mln remaining under the $500 mln share repurchase program authorized in April 2007.
08:13 AN authorizes an additional share repurchase of $250 mln

08:13 AN prelim $0.39 vs $0.38 Reuters consensus; revs $4.6 bln vs $4.69 bln Reuters consensus

08:12 NSC Norfolk Southern beats by $0.05, misses on revs (54.00 )

Reports Q3 (Sep) earnings of $1.02 per share, excluding non-recurring items, $0.05 better than the Reuters Estimates consensus of $0.97; revenues fell 1.7% year/year to $2.35 bln vs the $2.4 bln consensus. CEO says, “Softness in certain segments of the economy resulted in reduced traffic volumes, which we were substantially able to offset through pricing gains and cost control. We remain confident in the overall strength of our franchise, and we continue to take a long-term perspective as we plan new traffic corridors, improve technology, and support our workforce with the tools necessary to provide superior service.”
08:12 AMG Affiliated Managers beats by $0.01, beats on revs (131.50 )

Reports Q3 (Sep) earnings of $1.56 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $1.55; revenues rose 23.2% year/year to $345.6 mln vs the $339.5 mln consensus.
08:12 MOT Motorola: Credit Suisse expects share and margin improvement in Q4 (18.95 )

Credit Suisse continues to believe MOT is well positioned for growth and margin expansion through handset cost reductions and accelerating growth in other segments; however, they believe challenges in the handset business are likely to persist near-term.
08:11 HPQ Hewlett-Packard: Credit Suisse believes Lexmark exit of 30% of inkjet business good for HPQ (51.86 )

Credit Suisse believes Lexmark’s decision to exit 30% of its inkjet printer business, a scenario that is reminiscent of early 2006 when Lexmark exited the low-end inkjet market, will provide Lexmark’s competitors with incremental market share opportunities. And given HPQ’s inkjet product portfolio and market dominance, they believe HPQ is best positioned to win this business. More importantly, if these share gains come smoothly for HPQ, they believe the pricing environment will improve and will drive margin improvement in IPG as well.
08:11 NOV Natl Oilwell Varco beats by $0.08, beats on revs (74.77 )

Reports Q3 (Sep) earnings of $1.02 per share, $0.08 better than the Reuters Estimates consensus of $0.94; revenues rose 45.1% year/year to $2.58 bln vs the $2.47 bln consensus.
08:10 SLAB Silicon Labs beats by $0.06, ex items, beats on revs; guides Q4 revs above consensus (41.33 )

Reports Q3 (Sep) earnings of $0.36 per share, excluding option expense as well as a $0.07 tax gain, $0.06 better than the Reuters Estimates consensus of $0.30; revenues rose 20.5% year/year to $87.9 mln vs the $83 mln consensus. Co issues upside guidance for Q4, sees Q4 revs of $93-97 mln vs. $90.00 mln consensus.
08:10 CBR Ciber appoints new Executive VP/Chief Financial Officer (7.74 ) -Update-

Co announces that Peter Cheesbrough will join the co on October 31, 2007 as Executive Vice President/CFO.
08:10 KMT Kennametal beats by $0.05, beats on revs; raises FY08 EPS guidance above consensus (82.58 )

Reports Q1 (Sep) earnings of $1.05 per share, excluding non-recurring items, $0.05 better than the Reuters Estimates consensus of $1.00; revenues rose 13.3% year/year to $615 mln vs the $600.3 mln consensus. Co raises guidance for FY08, sees EPS of $5.60-5.70 vs. $5.48 consensus. Worldwide market conditions support Kennametal’s expectations of continued top-line growth during the balance of fiscal 2008. Based on global economic indicators, the co believes that the softness in the North American market will persist. The company also believes that the European market will remain favorable, and that business conditions will continue to be strong in developing economies. While there remain some uncertainties and risks related to the macro-economic environment, fundamental drivers for global demand appear to be stable.
08:10 PCAR PACCAR beats by $0.04, beats on revs (50.38 )

Reports Q3 (Sep) earnings of $0.81 per share, $0.04 better than the Reuters Estimates consensus of $0.77; revenues fell 12.9% year/year to $3.45 bln vs the $3.21 bln consensus. PCAR to increase quarterly dividend by 8% to $0.18.
08:09 PRSP Prosperity Bancshares downgraded to Hold at Stifel (30.84 )

Stifel downgrades PRSP to Hold from Buy following earnings and given a more subdued outlook for earnings growth next year combined with a relatively full valuation at a time when they believe bank stocks will be hard-pressed to achieve any meaningful semblance of valuation improvement over the foreseeable future.
08:09 AMG prelim $1.56 vs $1.55 Reuters consensus, $1.54 First Call; revs $345.6 mln vs $339.46 mln Reuters consensus

08:08 NVGN Novogen NV-128 induces novel mode of cell death in cancer cells (7.70 )

Laboratory studies presented late yesterday at the annual AACR/EORTC/NCI Molecular Targets and Cancer Therapeutics conference demonstrate that the Novogen drug candidate NV-128 induces autophagy, a novel mode of cell death in multi-drug resistant ovarian cancer cells. The data were presented by Gil Mor, MD, Associate Professor, Department of Obstetrics and Gynecology, Yale University School of Medicine. NV-128 is a derivative of phenoxodiol, an investigational drug licensed by NVGN to Marshall Edwards (MSHL) that is now in Phase III clinical development for patients with late stage ovarian cancer.
08:08 FCX Freeport-McMoRan beats by $0.24, reports revs in-line (111.15 )

Reports Q3 (Sep) earnings of $2.52 per share, excluding non-recurring items, $0.24 better than the Reuters Estimates consensus of $2.28; revenues rose 209.7% year/year to $5.07 bln vs the $5.05 bln consensus. FCX’s pro forma consolidated sales volumes for 2007, including pre-acquisition Phelps Dodge sales, are currently projected to approximate 3.9 billion pounds of copper, 2.3 million ounces of gold and 68 million pounds of molybdenum. Projected sales volumes for the fourth quarter of 2007 approximate 875 million pounds of copper, 100 thousand ounces of gold and 18 million pounds of molybdenum. The achievement of FCX’s sales estimates will be dependent, among other factors, on the achievement of targeted mining rates and expansion plans, the successful operation of production facilities, the impact of weather conditions and other factors.
08:08 BTJ Bolt Technology beats single analyst estimate (40.20 )

Reports Q1 (Sep) earnings of $0.60 per share, $0.02 better than the single analyst estimate of $0.58; revenue rose 53% year/year to $15.3 mln vs the single estimate of $15.1 mln.
08:08 CBR Ciber misses by $0.01, beats on revs; guides FY07 EPS in-line, revs above consensus (7.74 )

Reports Q3 (Sep) earnings of $0.12 per share, $0.01 worse than the Reuters Estimates consensus of $0.13; revenues rose 7.7% year/year to $265.7 mln vs the $259.6 mln consensus. Co issues guidance for FY07, sees EPS of $0.48-0.50, compared to previous guidance of $0.48-0.51, vs. $0.49 consensus; sees FY07 revs of $1.054-1.060, compared to previous guidance of $1.035-1.045 bln, vs. $1.05 bln consensus.
08:08 RIMM Research In Motion downgraded to Hold from Buy at boutique firm TD Newcrest (124.53 ) -Update-

08:07 LVLT Level 3: Q3 results and guidance weak; expect to be broken up - CIBC (3.28 ) -Update-

CIBC notes LVLT reported Q3 results at the low end of guidance. Firm notes mgmt substantially lowered 4Q07 and 2008 guidance. The co is blaming the shortfall on temporary operating system issues, which are inhibiting its ability to provision services, and they believe will likely continue. Firm thinks the only way for LVLT to execute better and grow its firm value is to divide itself into four or more major cos. On a break-up value, the co looks inexpensive vs. peers (EQIX, CCOI, AKAM, TWTC), but at 11x EBITDA on a consolidated basis, it’s fairly valued.
08:07 NVT Navteq selected as preferred map provider for Helio’s LBS application initiatives (76.17 )

Co announces that Helio, a mobile service, has selected NVT to be its preferred map supplier for the co’s L.B.S. application initiatives. NVT data for the United States will be the mapping foundation for Helio’s location-based service offerings.
08:07 MSTR MicroStrategy announces that Yahoo! has expanded its agreement to use MicroStrategy for business intelligence reporting and analytics (86.24 )

Co announces that Yahoo! (YHOO) has expanded its agreement to use MicroStrategy for business intelligence reporting and analytics.
08:07 FCX prelim $2.52 vs $2.28 Reuters consensus, $2.26 First Call; revs $5.07 bln vs $5.05 bln Reuters consensus

08:06 SLAB sees Q4 revs $93-97 mln vs $90.00 mln Reuters consensus

08:06 MDP Meredith beats by $0.01, reports revs in-line; guides Q2 EPS above consensus; reaffirms FY08 EPS guidance (56.70 )

Reports Q1 (Sep) earnings of $0.68 per share, $0.01 better than the Reuters Estimates consensus of $0.67; revenues rose 4.7% year/year to $404.5 mln vs the $404.5 mln consensus. Co issues upside guidance for Q2, sees EPS of $0.72 vs. $0.67 consensus. Co reaffirms guidance for FY08, sees EPS of $3.50-3.55 vs. $3.56 consensus.
08:06 AFAM Almost Family announces acquisition of Quality of Life Home Health Care; expected to be accretive to earnings in 2008 (21.00 )

Co announces an agreement to acquire the assets of all the Medicare-certified home health agencies owned and operated by Quality of Life Holdings. The transaction is not expected to add materially to 2007 earnings but is expected to be accretive to earnings in 2008.
08:06 GLOI GlobalOptions Group prices a 4.5 mln share common stock offering at $4.50share (6.10 )

08:05 BIOM Biomira announces new data may help guide the clinical development of PX-478 and PX-866; PX-478 does not inhibit the levels of any of the other proteins (0.74 )

Co announces that preclinical data for its targeted anti-cancer drug candidates PX-478 and PX-866 were presented in a poster session yesterday at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The data may help to guide future clinical studies of these innovative small molecule compounds. A Phase 1 trial of PX-478 in patients with advanced metastatic cancers is in progress. Biomira expects to file an Investigational New Drug application for PX-866 early in 2008. The results show that PX-478 is highly specific for HIF-1 alpha and does not inhibit the levels of any of the other proteins tested. Additionally, this inhibitory effect is independent of the tumor suppressor genes VHL and p53, genes that may significantly impact how cancer cells respond to a variety of therapeutic interventions.
08:05 SLAB prelim $0.43 ex items vs $0.30 Reuters consensus; revs $87.9 mln vs $83.04 mln Reuters consensus

08:05 SSP EW Scripps likely to review newspaper assets in Q308; trust structure does not preclude sale options - FT Mergermarket (42.54 )

FT Mergermarket reports the co will likely review its newspaper assets for a possible sale in Q3 2008, a source familiar with the situation told mergermarket. The c ownership structure, and the family trust that in effect controls the co, would not necessarily be an impediment to such a sale, the source said.
08:05 PNK Pinnacle: Adjusting ests for current trends; all eyes on Lumiere Place - CIBC (27.46 )

CIBC is fine-tuning their 2007 and 2008 ests to reflect current business trends and positive bias. The near term catalyst is the December opening of Lumiere Place in St. Louis, which we believe could exceed initial expectations resulting in the shares moving higher. The primary drivers of firm’s est revision are state rev results below their 3Q07 forecasts in Louisiana and Indiana by 7.7% and 4.6%, respectively. Firm fine tunes their 3Q07 EBITDA est to $47.4 mln from $53.9 mln, while their new 2007 EBITDA est is $183.3 mln from $196.4 mln and their 2008 est is $237.1 mln from $244.7 mln.
08:05 GRIL Grill Concepts says reports strong comparable sales for 3Q07 (6.20 )

Co announces strong same-store sales increases at the company’s The Grill on the Alley and Daily Grill-branded restaurants for its fiscal third quarter ended September 30, 2007. The Grill on the Alley restaurants recorded 15.7% increases in comparable sales for its fiscal 2007 third quarter, and the Daily Grill restaurants posted same-store sales gains of 5.1%. The company’s consolidated preliminary same-store sales were 9.1 percent for the three months ended September 30, 2007.
08:05 KEM KEMET beats by $0.01, beats on revs (7.85 )

Reports Q2 (Sep) earnings of $0.13 per share, excluding non-recurring items, $0.01 better than the Reuters Estimates consensus of $0.12; revenues rose 18.4% year/year to $197.1 mln vs the $190.5 mln consensus.
08:04 NCX NOVA Chemicals misses by $0.02, reports revs in-line (38.73 )

Reports Q3 (Sep) earnings of $1.16 per share, $0.02 worse than the Reuters Estimates consensus of $1.18; revenues rose 2.5% year/year to $1.75 bln vs the $1.77 bln consensus. “We believe the very strong third quarte